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Summary 
The connection between a high intake of dietary plants and a reduced risk of degenerative 
diseases is supported by a large amount of epidemiological evidence. Emerging evidence 
from nutritional genomics suggest that plants exert their protective effect through affecting 
cellular signalling and gene expression. Aberrant NF-κB activation has been linked to various 
diseases, and several phytochemicals possess NF-κB modulating properties that could have 
potential in prevention of disease. In this thesis, the modulation of NF-κB activation by 
phytochemical-rich plant extracts was studied by the use of transgenic reporter mice. 
The aims of this project were to perform in vivo experiments with an extract combined of five 
efficient in vitro NF-κB inhibitors. Secondly, the thesis involved separate studies on the in 
vivo NF-κB modulating potential of three of the five dietary plants found in the combination 
extract.  
The treatment of transgenic reporter mice with combination extract significantly inhibited 
lipopolysaccharide (LPS)-induced NF-κB activity. The area under curve (AUC) was 35 % 
lower in the extract group compared to the control group (0-6 h). We found organ specific 
inhibition of NF-κB, particularly in the organs of phytochemical metabolisation, as well as in 
the male reproductive organs.   
The in vivo experiments with thyme, clove and walnut extracts revealed a significant 
difference of 104% higher overall NF-κB activation at 6 h in the walnut group compared to 
the control group. We also found organ specific NF-κB modulation by the single food 
extracts, particularly in the liver, spleen and the male reproductive organs 
We have found that food extracts can modulate LPS-induced NF-κB activation, on an overall 
basis, and in an organ-specific manner. Based on this thesis, further work to elucidate the 
mechanisms of action of the NF-κB modulating food extracts is a possible future area of 
priority. 
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1. Introduction 
1.1 Nutritional science approaches 
Traditional epidemiology and physiology, though still fundamental to nutritional 
science, have been complemented by a notable focus on genetics and molecular 
biology, particularly during the last two decades. There has been a growing awareness 
among nutritional scientists that, to be fully understood, nutrition’s role in disease 
prevention and health should be investigated at the molecular level. According to 
Müller and Kersten, there are three main reasons for the expanded focus in nutritional 
scientific approach (1): 
• Completion of large genome projects has provided a multitude of genetic 
information, making it possible to study nutrition from this specific point 
of view.  
• The fact that compounds in food, such as micronutrients, macronutrients 
and phytochemicals can act as dietary signals influencing the metabolism 
has been recognised and implemented in research approaches.  
• The importance of genetic predisposition in the context of diet related 
diseases has been acknowledged.  
This field of study is referred to as nutritional genomics, or nutrigenomics, and aims at 
revealing the genome wide influence of nutrition on homeostasis. Nutrigenomics are 
investigated by two different approaches, providing complimentary information. 
Figure 1.1 presents a schematic overview (1). 
Figure 1.1. The combination of methods in nutrigenomics.  Molecular tools can be used to discover dietary 
target genes and the mechanisms involved in their regulation (left), and systems biology can  identify molecular 
biomarkers, as well as target genes and mechanisms. Dietary advice can prevent disease (right). From Müller 
and Kersten (1).     
The first approach is the use of for example cellular models and transgenic mice to 
study genes and the proteins they code for, their regulatory pathways and how they are 
affected by dietary factors (1). The second is systems biology, which is still in its 
scientific infancy, but is given huge expectations for future research. Systems biology 
is the study of complex interactions in a biological system and the dynamic 
relationships between biological molecules, as opposed to the classical reductionist 
approach in science. Nutritional systems biology will combine data on the 
transcriptome, proteome and metabolome to identify molecular biomarkers, targets 
and mechanisms involved in the interplay between diet and health (1).  
The two approaches combined can provide a better understanding of biological 
dysregulation that leads to diet-related diseases, and to identify genotypes that bear a 
larger risk of developing these diseases (1). Such knowledge could lead to adjustment 
of dietary recommendations on basis of genetic information, a possibly valuable tool 
for composing personalized diets for people with a genetic susceptibility to develop a 
specific disease. While tailor-made diets might be a future scenario in nutrition, there 
is a great potential of improvement of public health by influencing dietary habits at a 
general population level.  
1.2 Dietary plants and health 
The connection between a high intake of dietary plants and a lower risk of 
degenerative diseases such as cardiovascular disease, several types of cancer and 
diabetes, is supported by a significant amount of epidemiological evidence. The World 
Health Report 2003 from the World Health Organisation (WHO) states these facts 
about the consumption of fruits and vegetables and health (2): 
• Insufficient intake of fruits and vegetables is estimated to cause 19% of 
gastrointestinal cancer, 31% of ischaemic heart disease and 11% of stroke on a 
global basis.  
• Low fruit and vegetable intake is among the top 10 selected risk factors for 
mortality.  
• Sufficient intake of fruit and vegetables could prevent 2.7 million deaths 
annually.   
The association between health and diets rich in plant based foods has been studied for 
many years and by many strategies, molecular as well as epidemiological. The positive 
effects of e.g. vitamins, minerals and dietary fibre are well established, but new insight 
in molecular pathways of dietary components is adding new levels to the significance 
of diet. Emerging evidence suggest that the protective effects of plants also could be 
carried out through components that affect cellular signalling and gene expression. 
1.3 Phytochemicals 
As “phyto” is the Greek word for plant, these chemicals are accordingly plant specific. 
Phytochemicals are secondary metabolites of plants, with the purpose of protecting the 
plant from different types of stress, for instance radiation, microorganisms and insects. 
Several phytochemicals possess bioactive properties that have been associated with 
reduced risk of many diseases (3-5).  
The first documented discovery of phytochemicals was made by the Hungarian 
biochemist Dr. Szent-Gyorgyi in 1936. He found that compounds isolated from citrus 
fruits very efficiently improved capillary fragility, and he identified the active 
substances to be pure flavons or flavonol glycosides (6). He suggested that these 
compounds were of vitamin nature, and named them “vitamin P” for “permeability”.  
Phytochemicals have been subject to extensive research during the last decades, and 
thousands of compounds have been isolated from plant foods. However, more than 
seventy years after Dr. Szent-Gyorgyi’s discovery, previously unidentified 
phytochemicals are still being isolated and their bioactive properties investigated. 
Figure 1.2 shows one classification of dietary phytochemicals (7). The phenolics and 
the carotenoids are the most studied groups.  
Figure 1.2. Classification of dietary phytochemicals. From Liu (7).  
Alkaloids, organosulfur compounds and other nitrogen-containing 
compounds 
Secondary plant metabolites containing nitrogen make a large and extremely diverse 
group of phytochemicals. They exhibit many different functions in plants, such as 
defence against herbivores and microorganisms, chemical attractants in flowers and 
mechanisms for transport and storage of nitrogen (8). The main groups are alkaloids, 
amines, non-protein amino acids, cyanogenic glycosides and glucosinolates (8). Only a 
few of these compounds have been extensively studied with respect to biological 
activity.  
The alkaloid caffeine has been extensively studied because of its widespread 
consumption through coffee and tea, in particular. Caffeine consumption has been 
studied in association with diseases such as coronary heart disease, arrhythmia and 
pancreatic cancer, but studies have failed to show definitive correlations (9).  
Animal studies suggest that caffeine can provide protection against skin cancer both 
by ingestion and topical application (10). A human cross-sectional study revealed that 
consumers of caffeinated coffee have a lower prevalence of skin cancer, and that risk 
decreases further with increased intake, whereas this effect was not shown for those 
drinking decaffeinated coffee (10).  
Sulphoraphane, an organosulfur compound of the glucosinolates present in broccoli, 
has been shown to protect against tumorgenesis in animal models, and epidemiological 
studies have also shown that a diet rich in broccoli can reduce cancer risk (11). 
Carotenoids 
Carotenoids are lipophilic pigments present in plants, microorganisms and animals. 
They are responsible for many of the red, orange and yellow colours found on fruits 
and plants, as well as some fish, insects and crustaceans (12). They play important 
roles in protecting the organism from light damage by scavenging singlet molecular 
oxygen and peroxyl radicals (7;12). Most carotenoids are built up of a 40-carbon 
skeleton of isoprene units, with a pattern of conjugated double bonds along the 
backbone, causing different light absorption and antioxidant properties. More than 600 
different carotenoids have been identified; α-carotene, β-carotene, β-cryptoxantin, 
lutein, zeaxantin, astaxanthin and lycopene being the most common in our diet (7). 
Ingested carotenoids can have pro-vitamin A (α-carotene, β-carotene, β-cryptoxantin) 
roles. Because of their lipophilic nature and antioxidant capacity, the carotenoids are 
thought to play an important role in protecting cellular membranes and lipoproteins 
against oxidative damage (12). One of the most extensively studied carotenoids is 
lycopene. Several studies have reported that lycopene intake is inversely related to 
many types of cancers, such as prostate, breast, cervical, ovarian and liver cancer (13). 
Phenolics  
The most abundant antioxidants in the diet are the phenolics, and several hundred 
different types have been identified in food materials so far (4). The main types are 
flavonoids, phenolic acids, stilbenes, coumarins and tannins (7). Flavonoids and 
phenolic acids make up the lion’s share of phenolics in a regular diet. Table 1.1 
presents an overview of common phenolics in foods.  
Table 1.1. Overview of some common phenolics and example food sources. (7;14-17). 
Polyphenol  General chemical 
structure 
Example food sources 
Phenolic acids   
Hydroxy benzoic acids    
Gallic acid   Tea, spices 
Protocatechuic acid   Red berries, onion, spices 
    
Hydroxy cinnamic acids   
Caffeic acid   Fruits, spices 
Chlorogenic acid   Coffee 
Ferulic acid   Cereals 
Flavanoids    
Flavonols   
Quercetin   Onion, tea, apples 
Kaempferol   Tea, spices 
Myricetin   Tea, coffee 
Flavones    
Apigenin   Parsley
Luteolin   Celery 
    
Flavanols    
Catechin   Green tea, chocolate, spices 
Epicatechin   Fruit
    
Flavanones    
Eriodictyol   Lemon 
Hesperitin   Orange 
Naringenin   Grape fruit 
Anthocyanidines    
Cyanidin   Red berries 
Peonidin   Wine, cherry 
Delphinidin   Wine, blueberry 
Isoflavones   
Daidzein   Soybean 
Genistein   Soybean 
Glycitein   Soybean 
 
Phenolic acids are divided into hydroxybenzoic acids and hydroxycinnamic acids. 
Hydroxybenzoic acid content in foods are generally low, except from onions and red 
berries (14). Hydroxycinnamic acids are more common in foods. They are present in 
most fruits and are also found in high levels in cereals (14).  
Flavonoids have a common structure where two aromatic rings are linked by three 
carbon atoms in an oxygenated heterocycle ring. They are classified into six 
subclasses, flavonols, flavones, flavanols, flavanones, isoflavones and anthocyanins, 
depending on the structure of the heterocycle ring (7). Flavonols are the most common 
group of flavonoids in foods (14).  
Many phenolics have been extensively studied, but there is a lack of conclusive 
evidence concerning their role in disease prevention. A protective effect of a 
compound can be accompanied by an adverse effect, e.g. for resveratrol, that has 
shown an anticarcinogenic effect, but also increase the risk of cardiovascular disease 
in mice (4). Clinical studies have often shown contradictory results, and the possible 
relationship between reduced disease risk and the phenolics mechanisms of action is 
still unclear (4).  
1.4 Phytochemicals and diet 
1.4.1 Bioavailability 
When dietary plants are eaten, only a fraction of available micronutrients and 
phytochemicals are absorbed (18). After absorption, there are several processes 
contributing to the total bioavailability of a compound. A definition of bioavailability 
is given by the acronym LADME (18): 
 
 Figure 1.3. The linked processes that together define bioavailability. From Holst et. al (18).    
Up to several grams of phytochemicals may be ingested every day through eating a 
regular diet, however the concentrations measured at systemic and tissue levels are in 
low micromolar ranges (14). There are many reasons for this. First of all, to be 
absorbed the phytochemical needs to be accessible. If the compound is trapped within 
the matrix of the food, it will pass through the digestive tract unabsorbed. Accessibility 
can be greatly influenced by food processing and digestion in the gut. One example is 
the carotenoid lycopene in tomatoes, which is available in a much larger amount after 
heat treatment, as this releases the compound from the tomato peel (19). The 
mechanisms involving intestinal absorption of phytochemicals are still not fully 
understood. Most of the phenolics are hydrophilic molecules which cannot pass the 
intestinal wall by diffusion, and specific membrane carriers to facilitate transport have 
not been found (14). 
Many phenolics are handled by the body as xenobiotics, and undergo phase I and II 
metabolism in the small intestine and the liver, which results in methylated, sulfated 
and glucoronidated versions of the compounds. This process reduces the possible toxic 
potential and results in stable, water soluble metabolites (14). Phenolic metabolites in 
circulation are mainly bound to albumin. The effect of the binding is not clear, but 
could possibly facilitate antioxidant effects to the interface between lipophilic and 
hydrophilic phases (14). To what extent phenolics are absorbed in tissue is still not 
thoroughly investigated. However, accumulation of phenolic metabolites in tissue has 
been reported, suggesting that they might be able to exert tissue specific effects (14). 
Carotenoids do not undergo conjugation during metabolisation. They are incorporated 
unchanged into micelles of dietary fat and bile acids, which are absorbed by passive 
diffusion into the mucosal cells. The micelles are taken up in the chylomicrons and 
released into the lymphatic system. In the liver, they are incorporated into the 
lipoproteins, and released into circulation. The adipose tissue is the main storage site 
of carotenoids (13). 
Metabolites of phytochemicals can be excreted from the body by biliary and urinary 
elimination. Small conjugates are normally excreted in urine, whereas larger, more 
complex metabolites are preferably removed by bile (14). The compounds that are not 
absorbed may still play a significant role by local effects in the gut. As the gut has an 
important role in the immune defence, this may lead to indirect systemic influence 
(18). In the colon, microorganisms break down the phytochemicals and form new, 
possibly bioactive products. The microbial metabolites are absorbed and conjugated, 
and the products from colonic microflora can have specific activities. One example is 
the microbial transformation of soy isoflavones to equol, a nonsteroidal estrogen 
compound probably responsible for the pseudo-hormonal effect of soy (18). 
1.5 Oxidative stress and antioxidant defense 
1.5.1 Oxidative stress  
Oxidant agents include reactive oxygen species (ROS) and reactive nitrogen species 
(RNS), and are recognized to have both beneficial and detrimental roles in living 
organisms. Oxidant agents are radicals, molecules that contain unpaired electrons 
which makes them highly reactive. The oxidant agents originate from endogenous and 
exogenous sources. Mitochondrial respiration generates ROS, the superoxide anion  
(O2-) and hydrogen peroxide (H2O2) from molecular oxygen (O2) in the electron 
transport chain. Mitochondrial nitric oxide synthase activity generates RNS. Other 
cellular processes such as metabolisation of xenobiotics, inflammatory reactions and 
peroxisomal β-oxidation of fatty acids also generate ROS (20). Exogenous inducers of 
ROS can be environmental pollutants, smoking, xenobiotics, UV radiation, alcohol 
and infectious agents (21-23). When there is an overproduction of ROS, and the 
presence of antioxidants is too low, oxidative stress can occur. Oxidative stress can 
damage or inhibit the normal function of important cell components such as lipids, 
proteins and DNA. On the other hand, production of ROS is essential in e.g. defence 
against microbes or function as second messengers in cellular signalling (23). There is 
a delicate balance between harmful and essential levels of ROS, and living species 
utilizing oxygen have evolved endogenous systems to regulate the amount of free 
radicals in the cells.   
1.5.2 Antioxidant defense  
Both non-enzymatic antioxidants and enzymatic antioxidants can contribute to the 
elimination of ROS or to the prevention of ROS production.  
Enzymatic antioxidants include superoxide dismutase (SOD), catalase (CAT) and 
glutathione peroxidase (GPx)(24). SOD is a very effective endogenous antioxidant, 
catalyzing the reaction where O2- is converted to the less reactive H2O2 and O2.  
There are three types of SOD in humans, cytosolic, mitochondrial and extracellular, 
and aberrant levels of mitochondrial SOD are correlated with certain types of cancer 
(25). Catalase is located in the peroxisomes of the cell, where it catalyzes the 
conversion of H2O2 to water and molecular oxygen. Some tumours may have a 
reduced ability to convert H2O2, caused by a reduced level of catalase (25). 
Glutathione peroxidase is a family of both intra -and extracellular enzymes, reducing 
both hydrogen peroxide and lipid hydroperoxides (26). 
Non-enzymatic antioxidants are supplied both from the diet and from endogenous 
production. There is extensive interaction and co-operation between them, and they are 
likely to co-operate with the antioxidant enzymes in the management of oxidative 
stress (26). Vitamin C, vitamin E, glutathione, thioredoxin and lipoic acid are assumed 
to be some of the important non-enzymatic antioxidants (26). 
1.5.3 Antioxidants in disease prevention 
Many diseases include oxidative damage as an initial event or in early stages of 
disease development. “The antioxidant theory” ascribed natural processes like 
senescence and development of degenerative diseases to cellular oxidative stress. The 
in vitro antioxidant properties of many phytochemicals and some vitamins brought 
about the use of “antioxidants” as a collective term (18). The protective effects of 
dietary plants have partly been attributed the antioxidants hypothesized ability to 
reduce reactive oxygen species in vivo, thereby preventing oxidative stress. 
Dietary antioxidants have been proposed as a potential “magic bullet”, possibly 
responsible for the protective properties of phytochemical rich foods towards several 
degenerative diseases. Antioxidant intervention has been a major focus in dietary 
disease prevention, and the commercial industry producing antioxidant supplements 
has had a period of tremendous growth. 
Early hypotheses of the phytochemicals protective effect have been heavily 
challenged. In vitro and animal studies have reported protective effects that have not 
been reproduced in humans, making it difficult to evaluate the phytochemicals role in 
disease prevention (4). Several intervention studies have failed to show protective 
effects of antioxidant supplements in vivo (27-29). These studies were designed to 
show protective effect of high doses of antioxidant phytochemicals and vitamins, 
alone or in combination. Meta analysis of antioxidants supplement trials suggest that 
such high dose-supplements might even be harmful (27-29). Several micronutrients 
follow a u-shaped curve, ranging from risk of deficiency in one end to possible 
adverse effects in the other. The “window” of optimal, protective level can vary a lot 
between compounds, and for many phytochemicals these ranges have not yet been 
assessed (18).  
Several problems need to be addressed before conclusions can be drawn, concerning 
how the antioxidant properties of phytochemicals may contribute to the protective 
effect of dietary plants: 
• Whether small molecule antioxidants, which work as antioxidants in vitro, also 
have the same effect in vivo, is not established (18;30). 
• Some phytochemicals undergo extensive metabolisation during absorption, 
making the molecular effects found in vitro potentially irrelevant in vivo. 
• The possible combinatorial and/or synergistic effects between metabolites are 
very complicated to measure (30). 
• The phytochemicals are present in blood and tissue at concentrations far below 
those of endogenous antioxidants such as glutathione. In this context, the 
contribution of dietary antioxidants to the total antioxidant potential might be 
next to negligible (18). 
• The effects of dietary antioxidants may be related to interactions with 
intracellular signal cascades (18). 
1.5.4 Gene regulation  
Cells communicate and respond to extracellular stimuli by signal transduction. This 
process enables the cell to transmit information from the outside to functional elements 
inside the cell. Extracellular signalling molecules such as cytokines, hormones, growth 
factors and neurotransmitters activate cell signalling pathways, leading to activation of 
target gene transcription (23).  
Many phytochemicals with in vitro antioxidant properties have functions beyond 
radical scavenging. More and more studies suggest that the protective effects of 
phytochemicals can be related to the ability to modulate signal transduction pathways 
(31). Phytochemicals or their metabolites may influence transcription of genes by 
activation or repression of transcription factors, effects that can occur at concentrations 
much lower than what is relevant for antioxidant activity (30). As dietary plants 
contain an abundance of phytochemicals, the combination provided by a varied diet 
can affect the genetic machinery by a multitude of possible mechanisms of action.  
Phytochemicals processed by the body via xenobiotic pathways may activate specific 
or general cellular response to oxidative stress and toxin exposure. In this way, the 
phytochemicals could act as indirect antioxidants. Thus the phytochemicals may 
prepare the cell for more severe oxidative stress by activating signalling pathways that 
lead to upregulation of cytoprotective proteins. This phenomenon has been described 
as “preconditioning” or “hormesis” (32).  
The term hormesis has been used to describe the adaptive response of cells and 
organisms to moderate stress, and can explain the biphasic dose response curve of 
chemicals that have stimulatory effects at low doses, but are toxic at high doses (32). 
Hormetic pathways activated by phytochemicals can induce expression of genes that 
code for antioxidant and cytoprotective enzymes (32). An example of this is the 
activation of the Nrf2/Keap1 (nuclear factor erythroid2-related factor/kelch like ECH-
associating protein 1), pathway, which can be activated by e.g. sulforaphane or 
curcumin, phytochemicals present in broccoli and turmeric, respectively (18;32). Nrf2 
regulates expression of a large number of genes in antioxidant function and xenobiotic 
detoxification. Also, the nuclear factor kappa B (NF-κB), an important transcription 
factor regulating cellular stress-, immune- and inflammatory responses, can be 
modulated efficiently by phytochemicals and phytochemical-rich plant extracts 
(33;34). 
1.6 The NF-κB family of transcription factors 
NF-κB constitutes a family of transcription factors that are expressed in most cell 
types and involved in a large number of cellular processes such as inflammatory 
responses, anti-apoptosis, cellular growth and differentiation (35). The wide range of 
inducers and the many target genes it affects bring about an understanding that NF-κB 
is a general mediator of stress response in the organism.  
Activation of NF-κB plays an important role in defence against bacterial or viral 
infections, and in regulating innate and adaptive immune responses in states of 
inflammation (36). Increased NF-κB activity in inflammatory conditions is a transient 
and self-limiting event, and reflects a normal immune response in the organism. 
However, aberrant activation of NF-κB is linked to many diseases with an 
inflammatory element, such as rheumatoid arthritis, asthma, atherosclerosis, 
Alzheimers disease, diabetes and various types of cancer (37;38). These discoveries 
have triggered extensive research into the transcription factor NF-κB, and great effort 
has been put into elucidating the molecular details of the signalling pathways and their 
regulation. 
1.6.1 The NF-κB proteins and signalling pathways 
In mammals, the NF-κB family consists of five members: Rel, RelA, RelB, p50 and 
p52 (39). They share a Rel homology domain (RHD), which is highly conserved in 
mammalian evolution. The RHD inhabits many domains that provide functionality, 
such as DNA binding, dimerisation, interaction with inhibitory proteins and nuclear 
localisation signal (NLS) (38). The NF-κB proteins form homo–and heterodimeric 
transcription factors. Most combinations can occur, with the exception of RelB which 
dimerises only with p50 or p52. The most common dimer is p50/RelA, and the term 
NF-κB is often used synonymously with p50/RelA. Dimer formation is necessary for 
DNA binding, as each subunit binds to one half site of the κB binding site (38).  
The activity of NF-κB is regulated in a way that allows rapid cellular response to 
stimuli that are perceived as threats to the organism. In non-stimulated cells, the NF-
κB resides in the cytoplasm, bound to inhibitors of NF-κB, the IκB proteins. The NF-
κB/IκB complex exist as a trimer (one NF-κB dimer bound to one IκB), or a 
heterodimer (one NF-κB monomer bound to an unprocessed precursor). The IκB 
proteins inhibit activation of NF-κB by impeding DNA binding and masking the NLS 
in the RHD (38). There are at least seven mammalian members of the IκB proteins, 
IκB-α, IκB-β, IκB-γ, IκB-ε, Bcl-3, p105 (precursor of p50), p110 (precursor of p52) 
and IκBR (38), which have different affinities for individual NF-κB protein 
combinations (33). Common features are the ankyrin repeats necessary for RHD 
interaction, the C-terminal acidic region necessary for inhibition of DNA binding and 
the C-terminal PEST-sequence (proline (P), glutamate (E), serine (S), and threonine 
(T) rich sequence) involved in protein degradation (38). The NF-κB and the IκB 
proteins are shown in figure 1.4 (39). 
 Figure 1.4. Schematic structure of the NF-κB and the IκB proteins. From Karin et al. (39). 
NF-κB can be activated by a large variety of stimuli, such as inflammatory cytokines, 
microorganisms, viruses, heavy metals, cigarette smoke, environmental toxins, 
xenobiotics and radiation (40;41). Through membrane bound receptors, extracellular 
signals lead to activation of an IκB kinase complex (IKK), which catalyses the 
degradation of the IκB protein. The IKK complex generally contains two kinase 
subunits, IKKα, IKKβ and a regulatory subunit called NEMO (NF-κB essential 
modulator). The kinase subunits of the IKK complex phosphorylate serine residues on 
IκB, which in turn lead to ubiquitination and eventually degradation by proteasomes. 
Liberated NF-κB dimers can then enter the nucleus and bind κB sites on the DNA. 
There are two main pathways for NF-κB signal transduction; the classical and the 
alternative (42), illustrated in figure 1.5.  
 Figure 1.5. Two main pathways lead to activation of NF-κB. The classical pathway (left), and the alternative 
pathway (right) From Karin et. al (35).  
The classical pathway is triggered by stimuli such as tumour-necrosis factor-α (TNFα), 
CD40 ligand (CD40L), interleukin-1 (IL-1) and lipopolysaccharide (LPS) (35), which 
leads to recruitment of several signal tranducing adaptor proteins, before the IKK 
complex phosphorylates the IκB protein (42).  
The alternative pathway is independent of the NEMO regulatory subunit, leads to 
phosphorylation of an IKKα dimer, and is triggered by members of the tumor necrosis 
factors (TNF) family other than TNFα. These factors specifically activate the IKKα 
(35). The alternative pathway is also dependent on adaptor proteins, as well as a NF-
κB inducing kinase (NIK) (42).  
Also, a third pathway has been described, “the atypical pathway”, which is 
independent of the IKK and triggered by DNA damage, e.g. from UV radiation (42).  
1.6.2 The NF-κB target genes 
Activated NF-κB migrates to the nucleus and can activate the expression of more than 
150 genes (43) that are divided into four classes according to functionality: negative 
feedback, immunity, anti-apoptosis and proliferation (35). Figure 1.6 gives a brief 
overview of some of the target genes. 
 Figure 1.6. The four major groups of NF-κB target genes. From Karin et. al (35).  
The negative feedback genes ensure that the response is attenuated, as IκB synthesis is 
a result of NF-κB activation. Newly synthesized IκB will inactivate remaining NF-κB 
in the cytoplasm, and also bind and inactivate DNA bound dimers in the nucleus (38). 
Concerning the immune response, NF-κB is both being activated by inflammatory 
cytokines, as well as inducing the expression of several cytokines and chemokines. 
Thereby the signal can spread from cell to cell. The immune response produces 
cytokines, chemokines, adhesion molecules, acute-phase proteins and pro-
inflammatory enzymes. The anti-apoptosis and proliferation groups of target genes are 
important for cell survival under stress, to ensure that the cell does not unnecessarily 
succumb to the stress (43).  
Pahl et al. (43) have reviewed the NF-κB target genes that are activated upon NF-κB 
signalling in a given cell. The specificity of the response is maintained by receptors 
and signal transduction molecules present in each cell type. There can be regulation at 
the transcriptional level, as some promoter/enhancer regions may require combined 
binding of additional transcription factors to trigger transcription of the target gene.  
If the additional contributors are not present, the NF-κB signal might not have an 
effect. The combinations of NF-κB dimers can also have preferences for binding sites 
on DNA, adding another level of selectivity. Possibly, the influence of NF-κB 
activation is even greater, as some of the target genes are transcription factors 
themselves, making NF-κB also an indirect inducer of transcription. Examples of this 
are the proto-oncogene c-myc and the tumor suppressor gene p53.  
1.6.3 NF-κB and cancer 
Cancer is not one, but many diseases, each with different characteristics and treatment 
options. The development of cancer can be influenced by a vast amount of factors. 
Concerning alterations in cell physiology, there are six hallmarks that collectively 
inflict malignant growth (44):  
• Self sufficiency in growth signals 
• Insensitivity to anti-growth signals 
• Tissue invasion and metastasis 
• Limitless replicative potential 
• Sustained angiogenesis 
• Evading apoptosis 
All six hallmarks can be affected by NF-κB target genes through the transcription of 
genes involved in cell proliferation, angiogenesis, metastasis, inflammation and 
suppression of apoptosis (31), making this transcription factor a promising target in 
chemoprevention.  
Aberrant activation of NF-κB can arise from different defects in the signalling system. 
One example is genetic abnormalities, such as mutated or truncated IκB, which causes 
Hodgkin’s lymphoma, a cancer of the lymph nodes. Also, overexpression of NF-κB or 
constitutive IκB kinase activity can contribute to cancer development (45).  
The pharmaceutical industry has made major efforts in developing efficient inhibitors 
of NF-κB. These include IKK inhibitors, NF-κB RNAi (RNA interference; 
degradation of NF-κB mRNA) and proteasome inhibitors (39). In 2006, Gilmore and 
Herschovitch (33) listed in 785 known inhibitors of NF-κB, and this number has 
probably increased since. Inhibitors include both natural and synthetic compounds, 
targeting the signal transduction at different steps.  
1.6.4 Modulation of NF-κB by diet 
Among the natural NF-κB inhibitors are many compounds originating from dietary 
components, and several dietary plants are efficient inhibitors of NF-κB activation in 
vitro. Table 1.2 presents some examples of dietary NF-κB inhibiting compounds. 
Table 1.2. Dietary components that have shown inhibitory effect on NF-κB (34;37;46).  
Compound  Origin 
Anethole   Fennel, anise, clove 
α‐Tocopherol   Nuts, grains, oils 
Apigenin  Oregano, onion 
Caffeic acid   Coffee, fruits, oregano, thyme, walnuts 
Capsaisin   Chilli 
Carnosol  Rosemary, thyme 
Clorogenic acid  Coffee, tea, walnuts 
Curcumin   Turmeric 
Eugenol  Clove, sweet basil 
Epigallocathecin  Green tea 
Genistein  Soy 
S‐allyl‐cycteine  Garlic 
Sulphoraphane  Cruciferous vegetables 
Quercetin  Onions, clove 
 
Paur et al. showed that extracts of oregano, thyme, clove, turmeric and coffee inhibited 
NF-κB activation in a monocytic cell line (34). The NF-κB modulating effect of these 
plant extracts may be mediated by the contents of known inhibitory compounds, as 
they all contain one or more of the compounds listed in table 1.2. Paur et al. also 
reported ten additional plant extracts with the dual ability to induce a basal activation, 
and inhibit NF-κB activation upon stimulation with bacterial lipopolysaccharide 
(LPS). Allspice, crowberry, walnut, wild strawberry and sunflower seeds were the 
most potent inducers of basal NF-κB activity (34).  
The majority of experiments concerning modulation of NF-κB have been performed 
by testing isolated dietary compounds in vitro. Such a reductionistic approach can 
cause additive, synergistic or antagonistic effects from whole foods to be disregarded. 
Foods with NF-κB modulating properties could have potential in prevention of 
disease, in delaying the disease onset or as therapeutic agents (37). Results from in 
vitro models need to be confirmed in animal and human studies before conclusions 
concerning the efficiency of NF-κB modulators can be drawn.  
2. Aim of the thesis 
This thesis adds to a series of projects that study the protective effects of dietary plants 
on human health. The search for dietary factors that inhibit or modulate NF-κB 
activation can be useful both in prevention and treatment of diseases. Earlier studies 
conducted by the Rune Blomhoff research group have shown that dietary plant 
extracts and phytochemicals hold NF-κB modulating properties in a monocytic cell 
line.  
This Master project was set up to continue the previous work by testing the effects of 
the best in vitro NF-κB modulators in vivo in transgenic NF-κB-luciferase reporter 
mice.  
The aim of this master thesis is to: 
• Test the effect of a combination extract, compiled of the most potent in vitro 
NF-κB inhibitors, in transgenic reporter mice. 
• Test the NF-κB modulating ability of three of the constituents from the 
combination extract one by one in transgenic reporter mice.  
3. Materials 
o Transgenic mice 
Transgenic mice  Distributor  Location 
NF‐κB‐luciferase mice  Cgene  Oslo, Norway 
o Transgenic mice equipment 
Equipment  Manufacturer  Location 
Cameo 25 Gas Syringe Filter, 
0.22 micron 
Osmonics Inc, DGA02025SO  Minnetonka, MN 
Centrifuge tubes, 15 and 50 
mL 
BD Biosciences  Franklin Lakes, NJ 
Feeding tube for oral gavage 
feeding (0.8 – 1.2 mm) 
AgnTho's AB  Lidingö, Sweden 
Micro tubes 1.5 mL  Sarstedt  Nümbrecht, Germany 
Omnifix (syringes) 1 and 10 
mL 
Braun Melsungen AG  Melsungen, Germany 
Sterican (needles) 0.15x16 
mm 
Braun Melsungen AG  Melsungen, Germany 
96 well plates  Sigma, M2936  St.Louis, MO 
 
o Chemicals 
Chemical/compound  Manufacturer  Location 
Albumin  Bio‐Rad Laboratories Inc., 
500‐0007 
Hercules, CA 
Argon  AGA, 100325  Oslo, Norway 
ATP (adenine triphosphate)  Roche Diagnostics  Ottweiler, Germany 
Coenzyme A  Roche Diagnostics  Ottweiler, Germany 
Corn oil Biochemika  Sigma, C‐8267  St. Louis, MO 
D‐Luciferin  Biosynth AG  Staad, Switzerland 
DTT (dithiothreitol)  Sigma  St. Louis, MO 
EDTA (diethylenediamine 
tetra‐acetic acid) 
Merck  Darmstadt, Germany 
Ethanol  Arcus AS  Oslo, Norway 
Isoflourane  Baxter AS  Oslo, Norway 
Methanol (HPLC‐grade)  Merck  Darmstadt, Germany 
MgSO4 • 7H2O  Merck  Darmstadt, Germany 
ddH2O   Millipore  Bedford, MA 
PBS (Phosphate buffered 
saline) 
Bio Whittaker, BE17‐512F  Verviers, Belgium 
Reporter Lysis Buffer  Promega, E3971  Madison, WI 
Sodiumacetate trihydrate  Riedel‐deHaën AG  Seelze, Germany 
Tricine  Sigma, T5816  St. Louis, MO 
 
o Dietary plant extracts 
Name  Botanical name  Producer  Location 
Combo extract       
Clove  Syzygium aromaticum  Krydd Huset  Ljung, Sweden 
Arabica coffee   Coffea arabica  CIRAD  Montepellier, France 
Oregano  Oreganum vulgare  Santa Maria  Mölndal, Sweden 
Thyme  Thymus vulgaris  Hindu  Bergen, Norway 
Walnut  Juglands regia  Diamond  California, USA 
Single extracts       
Coffee  Coffea arabica  Friele  Bergen, Norway 
Clove  Syzygium aromaticum  Santa Maria, 
Hindu 
Mölndal, Sweden 
Bergen, Norway 
Thyme  Thymus vulgaris  Santa Maria  Mölndal, Sweden 
Walnut  Juglands regia  Unknown  California, USA 
o Kits 
Kit name  Manufacturer  Location 
Bio‐Rad Protein Assay  Bio‐Rad laboratories Inc.,500‐0006  Hercules, CA 
 
o Instruments 
Instrument  Manufacturer  Location 
Biofuge Fresco  Heraeus Instruments  Osterode, Germay 
2510 Branson  Branson Ultrasonics Corp.  Dansbury, CT 
IVIS Imaging System 100 Series  Xenogen Corporation  Alameda, CA 
Labofuge 400e  Heraeus Instruments  Osterode, Germany 
Luminometer TD 20/20  Turner Designs  Sunnydale, CA 
Megafuge 1.0 R  Heraeus Sepatech GmbH  Harz, Germany 
Synergy 2   Bio Tek® Instruments, Inc  Winooski, VT 
Titertek Multiskan Plus  ELFAB  Finland 
 
o Software 
Software  Manufacturer  Location 
 
Living Image Software  Xenogen Corporation  Alameda, CA 
Microsoft Office XP  Microsoft Corporation  Redmond, WA 
Reference manager 12  ISI Research Soft  Carlsbad,CA 
SPSS 16 for Windows  SPSS Inc.  Chicago,IL 
 
4. Methods 
4.1 Dietary plants  
The choice of dietary plants used in this project was based on inhibitory effects on NF-
κB shown in previous experiments performed in the Rune Blomhoff group.  
A screening of plant extracts done by Paur et al. revealed that extracts of oregano, 
thyme, clove, turmeric, coffee, allspice, crowberry, walnut, wild strawberry and 
sunflower seeds were able to significantly reduce LPS induced NF-κB activity in vitro 
(34). A combination extract compiled of some of the best NF-κB inhibitors, (coffee, 
thyme, oregano, clove and walnut), showed synergistic effect in in vitro experiments. 
Subsequently, the combination extract was tested in transgenic reporter mice. One of 
three experimental rounds testing combination extract in vivo, amounting to 8 out of 
32 animals in total, was performed within this thesis. A logical continuation involved 
testing the constituents from the combination extract one by one. Extract of coffee had 
been tested previously in transgenic reporter mice by the Rune Blomhoff research 
group, resulting in significant reduction in LPS induced NF-κB activity (47). Single 
extracts of thyme, clove and walnut were tested in this project.  
4.2 Extract preparation 
The food materials were bought from local grocery stores in Oslo, from brands sold by 
most food chains and accessible to most of the Norwegian population. The 
combination extract was provided by my supervisor Ingvild Paur. 
Thyme and walnut were ground with a hand blender to a fine powder. This step 
assures that as large a portion of the phytochemicals as possible is accessible to the 
extraction fluid. For clove extracts, ground clove was used.  
Equal volumes of double distilled water (ddH2O) and methanol were used as solvents 
in the extraction. The dry sample, 10 g, was added 10-20 ml ddH2O and 10-20 ml 
methanol. The amount of liquid varied between the food materials, depending on how 
much was absorbed by the dry matter. Mixtures were sonicated in 0ºC water bath for 
30 min, centrifuged for 10 min at 4000 rpm and 4ºC before the liquid phase was 
transferred to small Erlenmeyer flasks. The centrifugation step was repeated once, 
with 5 min duration. The methanol and most of the water were evaporated on a hot 
plate under nitrogen gas flow, leaving a viscous fluid in the flasks. The extracts were 
diluted in corn oil to a total volume of 5 ml, resulting in a final concentration of 2 g of 
sample per ml extract. The extracts were transferred to airtight tubes, added argon gas, 
and kept at -70ºC.      
4.3 FRAP assay analysis 
To measure the total antioxidant capacity of the extracts used in the experiments, ferric 
reducing ability of plasma (FRAP) assay was used. The method was originally 
developed for use on plasma, but it can be used for other fluids as well. The method is 
based on a change in absorption that occurs when a ferric tripyrdyltriazine (TPTZ-
Fe3+) complex is reduced to ferrous tripyrdyltriazine (TPTZ-Fe2+). This reduction takes 
place at low pH, and causes an intense blue colour, with an absorption maximum at 
593 nm, to appear. The present antioxidants’ reducing ability is the limiting factor, as 
Fe3+ is added in excess, and the blue colour is a measure of total reducing ability of the 
sample of interest. See table 4.1 for details on the FRAP assay solution.  
Plant extracts were diluted 1000× in a solution of 10% ddH2O and 90 % methanol. 
Measurements of absorption change were detected by a Technicon RA 1000 system at 
600 nm.  
Table 4.1. Ferric reduction potential of plasma (FRAP) assay solution.  
Reagents  Component  Volume in solution
Acetat buffer  300 mM acetate buffer, pH 3.6 +   
C2H4O2 16 mL/L buffer solution 
25 mL 
HCl  40 mM  2.4 mL 
FeCl3  x 6 H2O  20 mM  2.5 mL 
TPTZ solution  250 mg in 5 mL methanol  155 μl 
4.4 Luciferase reporter system 
Bioluminescense occurs when luciferases, enzymes capable of producing light, react 
with specific substances and create a product molecule in an electronically excited 
state sufficient to emit a photon. The emitted light can be used as a detection system 
for luciferase activity, and when its genetic expression is controlled by a particular 
regulatory element, the luciferase acts as a reporter for this element. We have used the 
luciferase reporter system based on firefly luciferase for both in vitro and in vivo 
experiments. The luciferase is encoded by the LUC gene, which is coupled to a 
promoter with three binding sites for NF-κB. Activation by binding of NF-κB to these 
sites will result in production of luciferase. When the substrate D-luciferin is added, 
luciferase catalyzes the formation of oxyluciferin and CO2, creating a burst of light 
that decays to a stable, low level of sustained luminescence (48). Chemical reaction: 
 
Figure 4.1. Chemical reaction catalyzed by luciferase. From Berger et.al. (49) 
The oxidation reaction yields light of 550-570 nm wavelength, and this luminescence 
can be detected by a sensitive camera (molecular imaging) or by biochemical assays. 
An advantage of using LUC as a reporter gene is that the bioluminescence has little 
background, which makes this gene a reliable reporter of activity (50). 
4.5 In vivo experiments  
4.5.1 Mice as a models for human biology  
The biology of living organisms is extremely complex, and the metabolic pathways 
involved in homeostasis interact in seemingly indefinite ways. To elucidate some of 
the mechanisms present in biological systems, approaching the problem from a simpler 
starting point can reduce the immensity. Model organisms have been used for this 
purpose for more than a century, gradually contributing to our understanding of life 
sciences.  
Generally, model organisms should meet certain requirements; e.g. small size, short 
generation time, possibilities of genetic engineering and limited ethical considerations. 
Organisms such as the yeast Saccharomyces cerevisiae, the nematode Caenorhabditis 
elegans and the fruit fly Drosophila melanogaster have been very important to 
elucidate mechanisms of for instance cell cycle, differentiation and the genetics of 
embryogenesis, respectively. In this type of research, properties such as a small 
genome and a limited amount of cells are additional advantages.  
Research that aims at understanding human physiology or disease development, 
however, requires increased complexity of the model organism to resemble the human 
genetics and physiology. Despite having diverged 75 million years ago (51),  Mus 
musculus and Homo sapiens have a close genetic relationship, making the mouse a 
good model for human biology. The predicted gene numbers of mice and man have 
been oscillating, the numbers being continually adjusted, but the latest estimates are 
20000-25000 protein coding genes for both species (52;53). Approximately 99 % of 
the human genes have murine homologues (54), and this kinship results in many 
similar or identical biological pathways.  
A very useful feature of the mouse is the possibility to alter the genome, and still get 
fertile and viable progeny. New genetic material can be added by microinjection of 
zygotes or by embryonic stem cell technology. Genes can be mutated by homologous 
recombination, providing the opportunity to study the role of one specific gene, a so 
called “knock out”. Mice have the ability, either naturally or by genetic engineering,  
to develop human diseases; diabetes, atherosclerosis and heart disease, cancer, 
hypertension and osteoporosis, to name a few (54). This enables researchers to create 
models to investigate the mechanistic events in disease development.  
Through the years, a vast amount of information and experimental methods 
concerning mouse genetics have been built up. These are very valuable means for 
understanding the basis of both diseases and normal biological processes. Other 
properties that make the mouse a convenient model is its very small size and short 
generation time for a mammal. It is also relatively cost-effective (54). However, there 
are considerable ethical considerations concerning the use of laboratory mice.  
The animal experiments in this project were performed at the Department of 
Comparative Medicine. The department maintain strict access regulations to protect 
the welfare of the animals, and to ensure that only trained personnel are allowed to 
perform animal experiments. Prior to the start of the project, curriculum of the 
“laboratory animal science” course was read, and thorough practise training was 
completed. Based on these preliminary arrangements, access to the department was 
given.  
The mice used in this project were attended to as required by the guidelines of the 
Federation of European Laboratory Animal Science Associations (FELASA). All 
animal experiments were performed according to national guidelines for animal 
welfare.  
4.5.2 Transgenic NF-κB reporter mice 
Animal models can confirm in vitro data and provide new and supplementary 
information relevant to the in vivo situation (40). To test whether results seen in in 
vitro experiments also take effect in vivo, transgenic mice expressing luciferase were 
used. The luciferase production in these mice is activated by NF-κB activation, as the  
LUC gene is coupled to a promoter containing three binding sites for NF-κB. The 
protocol for generating transgenic mice was developed by Carlsen et al (50). For a 
schematic overview of the procedure, see figure 4.2. The genetic construct was 
incorporated into the mouse genome by microinjection of fertilized zygotes of 
superovulated females. The zygotes were then transferred to pseudopregnant 
recipients. The offspring (F0 generation) were tested by polymerase chain reaction 
(PCR) for presence of the construct. The F1 generation was analysed for transgenic 
expression, and crossed with wild type F1 mice to produce heterozygous individuals 
(50).  
  
Figure 4.2. Generating transgenic mice. From http://cancer.ucsd.edu/. Moores Cancer Centre. San Diego 
Medical Centre. University of California (55) .  
Experiment setup 
In each experiment the mice were randomized into a group receiving only corn oil 
(controls) and a group receiving the relevant extract. The experimental setup is 
illustrated in figure 4.3. 
 
Figure 4.3. The experimental setup of in vivo experiments. 
To ensure equal absorption conditions, the mice were fasted for 3 h prior to treatment. 
At time -3 h, the mice were anesthesized with isoflourane and shaved on the 
abdominal area to make the luminescence visible. Still under anaesthesia, they were 
injected intraperitoneally (i.p.) with 160 mg/kg D-luciferin. After 7 min incubation 
following injection the mice were imaged. Then they were fed 300 μl of either extract 
or control vehicle (corn oil) by oral gavage. See table 4.2 for details on treatments and 
amounts for experiments. 
Table 4.2. Distribution of mice, extracts and amounts used in in vivo experiments. 
Exctract  Contents provided  Dose  Mice  
Combination  Thyme, oregano, clove: 60 mg  
Coffee, walnut: 600 mg  
300 μl  16 control,  
16 extract 
(4 control, 4 extract 
done in this project) 
Thyme  Thyme: 600 mg  300 μl  13 control,  
12 extract 
Clove / 
Walnut 
Walnut: 600 mg                 
Clove: 600 mg                      
300 μl  9 control, 21 extract 
(10 clove, 8 walnut) 
 
At time 0 h, LPS (2.5 mg/kg in 100 μl phospate buffered saline (PBS)) was injected 
subcutaneously (s.c.) on the back, near the tail.  
LPS, a compound found in the outer membrane of gram negative bacteria, is a strong 
inflammatory inducer involved in the pathogenesis of sepsis. It is recognized by cell 
receptors and produces a systemic inflammation via two pathways, the TLR4-Bc110 
pathway and the ROS-Hsp27 pathway (21). The TLR4-Bc110 pathway involves 
recognition of LPS components by TLRs (Toll Like Receptors), which trigger the 
innate immune system (21). Activation of the ROS-Hsp27 pathway might be initiated 
by ROS-generating interactions with membrane lipids. This pathway is probably 
leading to decline in Hsp27 (Heat shock protein) phosphorylation and increase in 
IKKβ-IκBα phosphorylation (21). Both pathways are integrated at the IKK 
signalosome where phosphorylation of units in the IKK complex leads to translocation 
of NF-κB to the nucleus.  
 In vivo imaging was performed at -3, 0, 3 and 6 h as described in figure 4.3. (For the 
combination extract experiment, in vivo imaging was performed at -3, 0, 2, 4 and 6 h, 
in accordance with the earlier combination extract experiments performed). Injection 
of D-luciferin and the subsequent incubation was repeated at every imaging time. 
Directly following in vivo imaging at 6 h, the mice were euthanised and the organs 
(brain, lung, heart, thymus, spleen, kidney, liver, intestines, skin, muscle, adipose 
tissue, uterus or testicle and epididymis) excised. Ex vivo imaging was done before the 
organs were frozen in liquid nitrogen (except intestines) and then kept at -70 ºC for 
subsequent luciferase assay and protein content analysis. 
4.5.3 Measuring luminescence  
In vivo and ex vivo imaging 
The IVIS Imaging System was used to detect luminescence in in vivo experiments. 
Molecular imaging allows visualisation of biological processes within an intact living 
subject, and repeated measurements within the same animal are possible. In this way 
differences between animals will be less significant, as the animals can serve as their 
own controls (40).  
The imaging system consists of an ultrasensitive camera that detects photons generated 
by the luciferase activity. Both in vivo and ex vivo imaging were performed. Emitted 
light was detected for 1 min for most imaging. A few pictures reached saturation for 1 
min exposure, the measuring was then reduced to 30 seconds. Results were processed 
with Living Image software and presented as intensity maps (visually) or photon 
counts (numerically). 
When measuring in vivo luminescence, the mice were given D-luciferin 7 min before 
they were placed on the back in a light proof chamber. Quantification was done by 
putting equally sized marking rings on the images (Figure 4.4.). Luminescence emitted 
from the marked area was measured with Living Image software.  
 Figure 4.4. Example image of mice marked for in vivo measurement in the Living Image 
software.  
Measuring of organs ex vivo was performed 30 minutes after injection of D-luciferin. 
The organs were rinsed in PBS and placed on a black plastic plate in the light proof 
chamber. Quantification was done by putting marking rings or squares on the images. 
Grey scale images were used for reference of position. See figure 4.5A. Emitted light 
was measured with Living Image software. See figure 4.5B.  
  
A 
B 
Figure 4.5. Example image of organs marked for in vivo measurement in the Living Image 
software. Grey scale pictures were used for position reference (A). Luminescence measured is visible 
in the organs (B).   
Luciferase assay 
Measurements of luciferase activity in organs were also done by a luciferase assay 
(LUC assay). The organs (brain, lung, heart, thymus, spleen, kidney, liver, intestines, 
muscle, adipose tissue,uterus or testicle and epididymis) were homogenized in reporter 
lysis buffer, which breaks down the cell membranes, the homogenates were 
centrifuged for 15 min at 4 ºC, and the supernatant used for measurements. Intestines 
and skin were excluded from LUC assay due to difficulties in homogenisation, and 
subsequently unreliable measurements. Luciferase activity was detected in a TD-20/20 
luminometer after the addition of D-luciferin-containing assay substrate (Table 4.3). 
The assay substrate, 100 μl, was added to 20 μl supernatant, in duplicates. Luciferase 
activity measurements were adjusted according to protein content to even out 
differences in sample size or homogenisation efficacy.  
Table 4.3. Reagents and procedure for making LUC-assay solution.  
Reagent  Amount  
ATP (Adenosine triphosphate)  52,1 mg 
Coenzyme A  20,7 mg 
Tricine  358,4 mg 
MgSO4 x 7 H2O  92,2 mg 
DTT (dithiothreitol)  513,5 mg 
EDTA         
(Ethylenediaminetetraacetic acid) 
15 μl 
ddH2O  80 ml + Adjustment volume 
D‐luciferin (20 mg/ml)  650 μl 
 
 
 
oIngredients were mixed, pH adjusted t  7,4, and ddH2O 
dded to a total volume of 100 ml.  a
 
Protein content 
Bio Rad protein assay was used to measure the protein content of the homogenates. 
The assay is based on the Bradford assay, a spectroscopic method that detects a shift in 
absorbance caused by binding of the reagents to basic or aromatic amino acids in 
proteins. The absorbance, measured at 590 nm, is proportional to the protein content.  
The supernatant from the homogenates was diluted 10 to 200 times according to total 
protein content. Albumin standards to provide a standard curve, and samples, 10 μl of 
each in triplicates, were put into 96 well plates. Bio Rad assay solution, 200 μl, was 
added to each well, and absorbance was measured in a Titertek microplate reader using 
a 590 nm filter.    
4.6 Statistical analysis 
For in vivo experiments, non-parametrical Mann-Whitney U test was performed to test 
for differences between groups in small experiments with non-normal distributed 
observations. For comparisons with larger, merged experiments, Student’s T-test was 
used. All statistical analysis was performed with SPSS 16. All analysis were set to 
p<0.05 significance level. 
5. Results 
5.1 FRAP analysis 
FRAP assay was used to measure total antioxidant capacity of the extracts used for in 
vivo experiments. Results are given as mmol/100g original product, and listed in table 
5.1. Clove extract had the highest antioxidant capacity measured, with a FRAP value 
of 86.9 mmol/100 g. Walnut extract had the lowest FRAP value, 39.3 mmol/100g.  
Table 5.1. FRAP values of extracts used for in vivo experiments. 
 (* measurement done in 2008 (56))  
In vivo extracts  FRAP (mmol/100 g)   SD (mmol/100 g) 
Combination*  82,3  0,9 
Thyme  48,5  1,4 
Clove  86,9  2,0 
Walnut  39,3  10,3 
 
5.2 In vivo experiments 
The in vivo experiments followed as a continuation of experiments previously done on 
U937 3×κB-LUC cells in the Rune Blomhoff research group. These in vitro 
experiments revealed NF-κB modulating properties of among others thyme, clove, 
walnut, coffee, and oregano as well as with a combination extract made from all these 
five. The in vivo experiments were designed to test whether the effects on NF-κB 
activation were reproducible in an animal model. The extracts tested in transgenic 
reporter mice included the combination extract, and extracts of thyme, clove and 
walnut one by one.  
The mice were given 300 μl extract by gavage feeding in a single dose. Control mice 
were given 300 μl corn oil. All treatments received LPS, (2 mg/kg), and NF-κB 
activation was monitored by in vivo imaging at 0, 2, 4 and 6 hours for combination 
extract and 0, 3 and 6 hours for thyme, clove and walnut. 
5.2.1 Effect of combination extract on LPS-induced NF-κB activity 
Transgenic NF-κB-luciferase reporter mice were given combination extract per os in a 
single dose 3 h prior to LPS injection (0h). NF-κB activation was measured by in vivo 
imaging at -3, 0, 2, 4, 6h, ex vivo imaging (at 6h) and LUC assay of individual organs. 
Sample size: n=16 control, n=16 extract. Presented here are the combined results of all 
three repetitions of the experiments, as presented in the submitted manuscript (see 
appendix 2). The isolated results from the experiment performed within this thesis are 
attached in appendix 1. 
In vivo imaging 
Quantification of light emitted from whole mice revealed inhibition of NF-κB 
activation in the mice receiving the combination extract compared to control mice. 
One representative mouse from each treatment is shown in figure 5.1A.  
At 2 h (p=0.043) and at 6 h (p=0.041), the extract significantly inhibited the LPS-
induced NF-κB activation in the extract group compared to the control group by 40 % 
and 36 %, respectively (Figure 5.1B). Based on the area under curve (AUC) for 0-6 h, 
the reduction in the extract group is 35 % (p=0.040) compared to the control group 
(Figure 5.1C). 
 Figure 5.1. Effect of combination extract in transgenic NF-κB reporter mice. In vivo imaging.  
Mice were given combination extract or control vehicle 3 h prior to LPS injection (0h). A) In vivo 
images of one representative mouse from each group. B) Mean ± SEM fold change of luminescence 
(photons/sec/cm2/steradian) from the whole mouse minus head and extremities. C) The AUC was 
calculated for each mouse and compared between the treatment groups. The average photons emitted 
and AUC were compared with the Student’s t-test. * = p < 0.05 
   
Ex vivo imaging 
Organ specific NF-κB activation can not be detected by in vivo imaging. To evaluate 
differences organs (brain, lung, heart, thymus, spleen, kidney, liver, intestines, skin, 
muscle, white adipose tissue (WAT),uterus or testicle and epididymis) were excised 
and NF-κB activation was measured by ex vivo imaging.  
Ex vivo imaging after administration of the combination extract or vehicle control 
revealed a significant reduction of 0.53 fold (p=0.028) in the intestines of the extract 
group compared to the controls (Figure 5.2 A). Representative intestines from each 
group are shown in figure 5.2 B. The results for other organs (from the experiment 
performed within this thesis) are shown in appendix 1.  
LUC assay 
NF-κB activity was measured in homogenates of organs (brain, lung, heart, thymus, 
spleen, kidney, liver, muscle, adipose tissue, uterus or testicle and epididymis). 
The NF-κB activity was reduced by 0.67 fold (p=0.046) in the liver, 0.66 fold 
(p=0.007) in the testicles and 0.48 fold (p=0.021) in the epididymis in the extract 
group compared to the controls. In the spleen, the NF-κB activity was significantly 
increased in the extract group to 1.57 fold (p=0.047) of controls (Figure 5.2 C). There 
was a trend towards increase in the heart of the extract group compared to the control 
group, however not statistically significant. No differences between groups were 
detected in brain, thymus, lung, kidney, adipose tissue, muscle or uterus. 
 Figure 5.2. Effect of combination extract in transgenic NF-κB reporter mice.  
LPS induced luciferase activity in organs after administration of combination extract or control 
vehicle. Organs were excised and imaged 6 h post LPS injection, luminescence was measured by 
imaging in an IVIS 100 imaging system, and quantified using the “Living Image software”.  
A: Quantification of emitted light from intestines. Bars represent mean fold change + SEM.  
B: Representative intestines from one control mouse (left) and one combination extract mouse (right). 
C: Quantification of emitted light from organs by LUC assay. Organs were excised 6 h post LPS 
injection, measured for luciferase activity and corrected for total protein content. Bars represent mean 
fold change + SEM. * = p < 0.05 
5.2.2 Effect of single extracts; thyme, clove and walnut, on LPS-
induced NF-κB activity 
Transgenic NF-κB-luciferase reporter mice were given thyme/clove/walnut extract or 
control vehicle per os in a single bolus, 3 h prior to LPS injection (0h). NF-κB 
activation was measured by in vivo imaging at -3, 0, 3, 6h, ex vivo imaging (at 6h) and 
LUC assay of individual organs. For all results the samples sizes are: Thyme: n=13 
control, n=12 extract, clove: n=9 control, n=10 extract and walnut: n=9 control, n=8 
extract. 
In vivo imaging  
In vivo imaging of mice given the combination extract showed  inhibition of NF-κB 
activation. Interestingly, this effect is not seen for any of the single extracts. One 
representative mouse from each treatment is shown in figure 5.5.  
For the mice that received thyme extract (Figure 5.5.A), there are no differences when 
comparing AUC.  
For clove (Figure 5.5.B), the mean AUC for the mice receiving extract is 1.87 fold 
increased in the clove extract group compared to controls, however this difference is 
not statistically significant (p=0.243).  
The AUC of the walnut extract group (Figure 5.5.C) 1.85 fold increased compared to 
the control group. There is a trend towards a statistically significant difference 
between the treatments (p=0.093).  
 
 
Figure 5.4. Effect of single extracts in transgenic NF-κB reporter mice. In vivo imaging.  
One representative mouse from each group (control, thyme, clove and walnut) at 0, 3 and 6 hours is 
shown.  
 Figure 5.5. Effect of single extracts in transgenic NF-κB reporter mice, - AUC.  
Mice were given thyme (A), clove (B) or walnut (C) extract 3 h prior to LPS injection. The AUC was 
calculated for each mouse and compared between the treatment groups.  
 55
Looking at the time graphs (Figure 5.6A), there are no visible differences between the 
thyme and control group.  
The mice that received clove (Figure 5.6B) have a seemingly higher activation of NF-
κB than their control mice, but this difference is not statistically significant at any time 
points. (At 3h, p=0.278, at 6 hours, p=0.400)  
The walnut group (Figure 5.6C) also have a higher activation of NF-κB compared to 
their control group. At 6 hours, there is a statistically significant difference of 104% 
higher overall NF-κB activation in the walnut group compared to the control group  
(p = 0.027).  
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Figure 5.6. Effect of single plant extracts in transgenic NF-κB reporter mice. In vivo imaging.  
Mice received thyme (A), clove (B) or walnut (C) extract 3 h prior to LPS injection and imaged at  
-3, 0,3 and 6 hours. Time charts represent mean ± SD of fold change (photons/second) from whole 
mice minus head and extremities. * = p<0.05 
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Ex vivo imaging 
Ex vivo imaging after administration of thyme (Figure 5.8A) showed that NF-κB 
activity was increased 2.71 fold (p=0.046) in the epididymis in the extract group 
compared to the control group. No other organs showed significant change in NF-κB 
activation with thyme treatment compared to control.  
For the mice that were given clove extract (Figure 5.8B), there was a 0.54 fold 
(p=0.035) inhibition of LPS-induced NF-κB activity in the spleen as compared to 
control mice. No other organs showed significant differences compared to controls 
after this treatment.  
For the walnut treatment (Figure 5.8C), there was a tendency towards inhibition of 
LPS-induced NF-κB activity in the spleen, with a 0.61 fold (p=0.059) reduction for 
walnut versus control-treated mice. This reduction is, however, not statistically 
significant. No other organs show any statistically significant differences compared to 
controls among the walnut treatment group.  
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Figure 5.7. Effect of single plant extracts in transgenic NF-κB reporter mice. Ex vivo imaging. 
LPS induced luciferase activity in organs after administration of control vehicle or thyme, clove or 
walnut extract. Organs were excised and luminescence was measured by imaging 6 h post LPS 
injection. Pictures show representative mice from single extract experiments. A: Control, B: Thyme, 
C: Clove, D: Walnut. The order of the organs is identical for all sets. 
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Figure 5.8. Effect of single plant extracts in transgenic NF-κB reporter mice. Quantifications of 
ex vivo imaging. LPS induced luciferase activity in organs after administration of thyme (A), clove 
(B) or walnut (C) extract or control vehicle. Organs were excised 6 h post LPS injection and 
luminescence was measured by imaging in an IVIS 100 imaging system, and quantified using the 
“Living Image software”. Gray scale images were used for reference of position. Bars represent mean 
fold change + SEM. * = p<0.05 
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LUC assay 
NF-κB activity was measured in homogenates of organs (brain, lung, heart, thymus, 
spleen, kidney, liver, muscle, adipose tissue, testicle and epididymis).  
The NF-κB activity of mice given thyme extract (Figure 5.9A) increased 1.82 fold 
(p=0.046) in the liver, 3.06 fold (p=0.007) in the muscle and 5.82 fold (p<0.001) in the 
epididymis, as compared to control mice.  
The mice given clove extract (Figure 5.9B) showed a trend towards decreased  
NF-κB activity in the spleen, with a 0.68 fold (p=0.065) reduction compared to 
controls. No other organs showed differences between the two treatments.  
Walnut extract (Figure 5.9C) caused a 0.44 fold (p=0.036) reduction in NF-κB 
activity in the heart compared to the control group. There is also a tendency towards 
inhibition in the kidney, however the difference is not statistically significant 
(p=0.059).  
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Figure 5.9. Effect of single plant extracts in transgenic NF-κB reporter mice. LUC assay. LPS 
induced luciferase activity in organs after administration of thyme (A), clove (B) or walnut (C) extract. 
Organs were excised 6 h post LPS injection. Tissues were homogenised and luciferase activity was 
measured and corrected for total protein content of the sample. Bars represent mean fold change 
+SEM.* = p<0.05 
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6. Discussion  
6.1 Discussion of methods 
6.1.1 The luciferase reporter system 
The luciferase reporter system is based on production of luciferase from the LUC 
gene. Binding of NF-κB dimers will lead to activation of the transcriptional machinery 
and production of luciferase mRNA. Luciferase is rapidly translated into functional 
proteins, with a half life of approximately two 2 hours, which makes this enzyme a 
favourable reporter for fluctuating NF-κB activity (57). D-Luciferin is injected 
intraperitonally, providing a rapid distribution to all organs. Where luciferase is 
present, D-luciferin is oxidised to oxyluciferin, and light is emitted. D-Luciferin is 
given in excess to ensure that luciferase produced by NF-κB activation, and not the 
substrate, is the rate limiting factor in the enzyme reaction. 
The luciferase reporter system can detect low levels of gene expression, and the light 
emitted is largely correlated with the amount of luciferase present (57).  
The measurements are, however, compromised by a variable level of absorption of 
photons in different tissues. Haemoglobin absorbs light emitted from the luciferase/D-
luciferin reaction, which affects measurements especially in blood rich organs. Blood 
rich organs such as the kidneys, lungs and heart emit little light, which can lead to 
underestimation of NF-κB activation in these organs compared to other organs that 
contain less blood (50). This may, at least in part, explain the relatively low 
luminescence from kidneys, lungs and heart that can be seen with the naked eye on the 
ex vivo images in “Results”, Figure 5.7. 
Furthermore, there is a limitation as to which extent the luminescence can penetrate 
tissues. When imaging in vivo, luminescence from the deeper layers of tissue is less 
likely to be detected, and a disproportionate amount of the signal would come from the 
organs close to the surface, such as skin and muscle (57). This limitation will to some 
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degree also apply to ex vivo imaging, due to the relative difference in dimensions of 
the organs. It is reasonable to believe that in a small organ like the thymus, most of the 
luminescence occurring will be detected, whereas in larger organs, such as the liver,  
a smaller portion of total luminescence may be detected. However, as this will apply 
equally to all the animals used in the experiment, the relative differences measured 
will reflect a real difference in gene expression.  
Transgenic reporter mice and the luciferase reporter  
Methods involving in vivo imaging of model organisms have become valuable tools to 
study real time gene expression. These rapid and non-invasive assays allow multiple 
measurements within one animal. Several methods are used to image gene expression, 
among which positron emission tomography (PET), magnetic resonance imaging 
(MRI) as well as measuring green fluorescent protein, near infrared protein and 
luciferase are applied most frequently (57). 
In this project, transgenic mice expressing the LUC gene were used to measure LPS-
induced NF-κB activity and its possible modulation by plant extracts. When these 
mice are generated, multiple copies of a DNA construct, containing three κB binding 
sites upstream of the LUC gene, are incorporated randomly into the mouse genome. 
Activation of the LUC gene is dependent both on binding of the NF-κB dimer as well 
as the dimer’s ability to activate transcription, which makes luciferase a reliable 
reporter of this specific transcription factor.  
A disadvantage of the method is the randomness of genomic positioning and the 
unknown copy number of constructs inserted, as these factors will affect the 
transcription rate. More copies will give a higher expression level. For reporting 
purposes this can be beneficial, as an increased expression can increase the sensitivity 
of the method. However, differences in integration numbers between mouse lines can 
lead to large variations between experiments. Epigenetic differences may influence 
transcription levels, as insertion in heterochromatic areas of DNA can reduce or block 
transcriptional activation. The transcriptional activity rate of neighbouring DNA areas 
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can also influence the expression level, as certain DNA areas are more 
transcriptionally active than others.  
The design of the in vivo experiments can circumvent the above mentioned limitations 
of the luciferase reporter method to a certain extent. Firstly, all the mice used in this 
project are descendants of the same line; hence the copy numbers between the 
individuals are identical. Nevertheless, epigenetic variety may occur. Secondly, when 
luminescence is measured, the fold change in NF-κB activity from the time of LPS 
injection is calculated for all animals at all time points. This means that each animal 
serve as an internal control. As long as there are no differences concerning basal NF-
κB activity between the groups prior to treatment, a significant difference after 
treatment will reflect an effect caused by the treatment. Statistical tests, for the 
difference of the mean of the control and the extract group for each experiment, 
revealed no significant differences between the groups prior to treatment.  
LUC assay 
In addition to in vivo and ex vivo imaging, LUC assays were performed on all excised 
organs, except intestine and skin. In the LUC assay, the organs are homogenised in a 
lysis buffer solution, to compensate for the luminescence’ lacking ability to penetrate 
tissues. This will release the luciferase produced within the cells, and make it 
accessible to react with D-luciferin in the assay solution. The snap-freezing of the 
organs after ex vivo imaging stops all chemical reactions in the cells and preserves the 
luciferase within the tissue.  
6.1.2 FRAP measurements 
There are several ways of measuring total antioxidant capacity in food extracts. 
Corral-Aguayo et al. (58) measured total antioxidant capacity of food materials using 
six different assays: 2,2′-diphenyl-1-picrylhydrazyl (DPPH), N,N-dimethyl-p-
phenylendiamine (DMPD), ferric reducing ability of plasma (FRAP), oxygen radical 
absorbance capacity (ORAC), Trolox equivalent antioxidant capacity (TEAC) and 
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total oxidant scavenging capacity (TOSC), and found that there was a strong 
correlation between the total phenolics measured for all methods.  
The FRAP method is well established in our laboratory, and had been used in earlier, 
related work, which allowed comparisons with previous measurements. The FRAP 
method is rapid and straightforward, linearity is maintained over a wide range and it 
gives a direct measure of the reducing compounds in a sample (59).  
The combination extract used in this work was prepared and measured for FRAP in 
connection with earlier experiments (Table 5.1.). Extracts of thyme, clove and walnut 
have previously been determined for FRAP by Paur et al. (34), to values of 21.0, 141.5 
and 7.7 mmol/100 g, respectively. In this project, the extract of thyme and walnut had 
higher FRAP values, whereas the clove extract had a lower FRAP value than 
previously measured. Differences in amount of extraction fluid between extract 
preparations could explain some of the differences. The ratio between sample and 
solvent can affect the total content of phytochemicals extracted from the foods (60). 
The amount of solvent used in the extraction will also affect the time of evaporation 
under nitrogen, a preparation step that can cause phytochemicals to be lost in the 
vapour.  
When original plant components were assayed, Halvorsen et al. (59) found a FRAP 
value of 20.97 mmol/100 g for walnut. Dragland et al. (61) measured three types of 
thyme, with FRAP values ranging from 45.4-95.0 mmol/100g. They also determined 
clove to contain 465.3 mmol/100 g.  
In addition to preparation procedures, variations may be explained based on the 
species, growing conditions and production. Botanic varieties between producers, 
different countries of origin, the time and conditions of cultivation and storage before 
and during sale could influence the amount of phytochemicals in the plants (59).  
The FRAP analysis’ were performed to confirm that the extracts had turned out rich in 
phytochemicals. The total antioxidant capacity measured by FRAP reported a high 
content of reducing compounds in the extracts used in this project. Several studies on 
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similar types of food extracts have established a strong correlation between total 
phenolic content and total antioxidant capacity (17;62;63). It is reasonable to believe 
that a considerable share of the total antioxidant capacity is owed to phenolics in the 
extracts.  
6.2 General discussion 
A diet rich in plant-based foods can protect against many degenerative diseases, and 
this protection could, at least partly, be ascribed to bioactive phytochemicals and their 
influence on gene regulation. Plants contain thousands of chemical substances, and the 
possible interactions between the compounds found within one plant, not to mention 
the combinations provided from a varied, plant-based diet, are almost impossible to 
predict. Cellular signalling cascades of cells interact in complex ways. An effect on 
one specific cellular pathway observed in vitro might be altered by interacting cellular 
pathways in vivo.  
The link between aberrant NF-κB activation and diseases, especially some types of 
cancer, has made this transcription factor a popular target for research towards both 
prevention and treatment of these diseases. Research about NF-κB modulating 
properties of phytochemicals have largely been focusing on single compounds. From a 
nutritionist’s point of view, it is of great interest to study how whole foods can 
contribute to prevention of these diseases. Accordingly, the focus of this thesis is on 
the effect of extracts from whole foods. Also, most of the NF-κB modulating 
properties of phytochemicals have been demonstrated in vitro. In vivo data on NF-κB 
modulation by plant extracts are scarce. The use of transgenic luciferase reporter mice 
brings research about NF-κB modulations by phytochemicals to a new level.  
The work in this thesis is part of a larger project in the Rune Blomhoff research group, 
in which several plant-food extracts have previously been found to modulate NF-κB 
activation in U937 3×κB-LUC cells (34). A combination extract made from five of the 
most potent inhibitors (coffee, thyme, oregano, clove and walnut) from this previous 
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screening was also found to synergistically inhibit LPS-induced NF-κB activity in the 
U937 3×κB-LUC cells (64).  
Based on these findings, we proceeded to study the effect of the combination extract in 
vivo in transgenic reporter mice. We also decided to test whether the single 
components of the combination extract could modulate NF-κB activation in vivo one 
by one. The single plants chosen were among the most potent NF-κB inhibitors in in 
vitro experiments, and they were all parts of the combination extract. Coffee extract 
had previously been tested in vivo by Paur and Balstad et al. (47), with significant 
reduction in NF-κB activation as the result. Oregano and thyme had the most 
overlapping phytochemical profiles of the four remaining candidates, and thus we 
decided to leave out one of these. 
The results from the combination extract experiments showed significant inhibition of 
LPS-induced NF-κB activity for mice treated with combination extract compared to 
those receiving control vehicle only. The extract group had a 35 % lower activation 
based on total AUC (0-6 h).   
The in vivo experiments with single extracts did not confirm the inhibitory effects on 
NF-κB activity seen in vitro. Thyme extract did not modulate overall NF-κB activation 
in vivo in our experiment, and walnut showed an increase in NF-κB activity. Clove 
extract showed a trend towards increase in NF-κB activity.  
Both the combination extract and the single extracts caused organ specific alterations 
in LPS-induced NF-κB activity, and the effects from the combination extract and the 
single extracts are somewhat contradictory. Table 6.1 summarises the significant 
differences and possible trends of NF-κB modulations by plant extracts tested in this 
project. 
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 Table 6.1. Overview of the main findings from in vivo experiments with combination and single extracts.  
Treatment  Reduced NF‐κB 
activity 
Increased NF‐κB 
activity 
Overall NF‐κB activity     
Combination extract  35 % lower AUC  
(0‐6 h) 
 
Walnut extract    104 % higher fold 
change at 6 h 
Organ specific NF‐κB activity     
Combination extract  Intestines, liver, 
testicle, epididymis 
Spleen 
Thyme extract    Liver, muscle, 
epididymis 
Clove extract  Spleen   
Walnut extract  Heart   
Organ specific NF‐κB activity ‐ trends     
Combination extract     Heart 
Walnut  Kidney, spleen   
  
6.2.1 Phytochemical profile and bioactivity of the plants used in 
this project  
To identify the phytochemicals’ molecular mechanisms of action, a comprehensive 
analysis of the extracts would be necessary. This can be achieved by chromatographic 
methods, e.g. High Performance Liquid Chromatography (HPLC). The phytochemical 
profiles of the extracts used in this project are not known, but from analyses performed 
in other laboratories, we can assume a similar phytochemical profile of our extracts. 
Coffee (Coffea Arabica) contain a large number of phytochemicals, from which 
caffeic acid and chlorogenic acid constitute the major part of the phenolics (66). 
Coffee extract (30 mg/ml) inhibited LPS-induced NF-κB activity in vitro by 89 % 
(34). This inhibitory effect was subsequently reproduced in vivo (47).  
Thyme (Thymus vulgaris) has been reported to have a total phenolic content of  4.52 g  
per 100 g, and the major phenolic compounds are caffeic acid, p-coumaric acid, 
rosmarinic acid, gallic acid and thymol (17). Thyme extract resulted in a 88.7 % 
reduction in LPS-induced NF-κB activity in U937 3×κB LUC cells (34).  
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Walnuts, the seeds of Juglans regia, are rich in poly-unsaturated fatty acids (PUFA), 
which make them susceptible to oxidation. However, the walnut seeds are stable 
against oxidation, possibly due to their high content of phenolics with antioxidant 
capacity (67). The major fraction of phenolics are located in the pellicles, (the 
protective, brown skin that covers the kernel), while the seed itself contains relatively 
small amounts of phenolic compounds. Among the phenolics identified from walnuts 
are: Chlorogenic acid, caffeic acid, p-coumaric acid, ferulic acid and ellagic acid (68). 
Paur et al. (34) reported that walnut extract (30mg/ml) gave a 63.8 % reduction in 
LPS-induced NF-κB activity in U937 3×κB LUC cells.  
 
Oregano, Origanum vulgare, contains approximately 10.17 g phenolics per 100 g, and 
caffeic acid, p-coumaric acid, caffeoyl derivatives, rosmarinic acid, carvacrol and 
kaempferol are among the major contributors (17). Oregano was the most potent 
inhibitor of NF-κB activation by LPS in in vitro studies by Paur et al. (34), causing a 
91.4 % reduction compared to control.  
 
Clove, Syzygium aromaticum, has had its total phenolic content measured to 14.38 g 
per 100 g, with a substantial proportion made up of the phenolic volatile oil eugenol. 
Clove also contains quercetin (17).  Clove extract reduced LPS-induced NF-κB 
activity with 87.8 %  in vitro (34). Aggarwal and Shishodia (37) showed that eugenol 
and isoeugenol inhibit NF-κB activation by suppressing IκBα degradation in vitro.  
 
6.2.2 Effect of plant extracts on LPS-induced NF-κB activity 
In vivo imaging 
The mice receiving the combination extract showed a 35% reduction in LPS-induced  
NF-κB activation compared to controls, calculated as total AUC, and the overall 
difference between the treatment groups is statistically significant.  
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The combination extract is likely to contain a large number of the bioactive substances 
present in coffee, thyme, oregano, clove and walnuts, which could modulate NF-κB 
signalling in additive, synergistic and antagonistic ways.  
The in vivo imaging after administration of single extracts show a different effect on 
NF-κB compared to the combination extract. The 1.87 and 1.85 fold increases in the 
clove and walnut group, respectively, could indicate that these extracts, when 
administered alone, have an opposite effect on overall NF-κB modulation compared to 
the combination extract.  
An important factor to consider is the amount of phytochemicals provided by the 
extracts. The amounts given in one single dose of combination extract would convert 
to more than 100 cups of coffee, 1.5 kg walnuts and 150 grams of thyme, oregano and 
clove, respectively, for a person weighing 75 kg, provided that all the phytochemicals 
from the foods were extracted. Such a phytochemical dose could not be provided by 
any normal diet, and might be considered pharmacological. Still, in vivo effects caused 
by the plant extracts could be starting points for further research.  
The doses of both clove and thyme extracts were ten times higher than in the 
combination extract. The mice were given the maximum concentration possible to 
increase the possibility of observing an effect. The dose could have been lowered; 
however, as the mice receiving the combination extract got a higher total dose of 
phytochemicals than those receiving single extracts (Table 4.2), testing the single 
extracts with a maximum dose seemed rational. If such a dose exceeds a beneficial 
amount of phytochemicals, thereby provoking an inflammatory reaction in the 
animals, the increased NF-κB activity observed from the clove extract could be the 
result of a xenobiotic overload. 
Walnuts are generally considered anti-inflammatory, due to their high content of 
essential PUFAs. The phenolic ellagic acid has also shown potent anti-inflammatory 
effects in experimental studies (69). In this project, however, walnut extract was the 
only single extract that gave a significant increase in LPS-induced NF-κB activity.  
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The walnut dose was the same as in the combination extract. In vitro; walnuts showed 
the strongest effect among the foods tested, to both induce basal activity and inhibit 
LPS-induced activity of NF-κB (34). If this also applies to mice, the LPS-induced NF-
κB activity could come on top of an increase in basal activity, possibly explaining 
some of the increase in NF-κB activity measured.  
Ros (69) evaluated nuts in the context of cardiovascular disease, and put forward a 
suggestion that oxidation-prone PUFAs from walnuts could enhance oxidation, unless 
counterbalanced by antioxidants. The role of oxidative stress in NF-κB activation is 
much disputed, even though some scientific publications state the redox sensitivity of 
NF-κB as a matter of course. Early hypothesis’ predicted NF-κB to be redox sensitive 
(70), however opinions among scientists in the field seem to be split. Provided that 
NF-κB is a redox sensitive transcription factor, this argument could fit the observation 
that walnut alone led to increase in NF-κB activity, whereas walnuts in combination 
with other phytochemical-rich foods attenuated the response.  
A large share of the activity measured by in vivo imaging is probably originating from 
the liver. The livers of mice comprise a large percentage of the body weight compared 
to humans. The intense light signal seen by in vivo imaging (Figure 5.1A and Figure 
5.4) after LPS injection, at the upper part of the abdominal area, seems to correspond 
with the position and size of the liver. High activity in the liver measured by both ex 
vivo imaging and the LUC assay supports this interpretation. The absolute NF-κB 
activity in the liver (adjusted for protein content) is among the highest of all organs, 
and combined with the large size, the liver contributes considerably more than any 
other organ to the overall NF-κB measured in vivo. 
Ex vivo imaging and LUC assay 
The analyses of organs by ex vivo imaging and the LUC assay can further specify the 
source of NF-κB activation measured by in vivo imaging. Altered NF-κB activity in 
organs could reflect bioavailability and specific tissue distribution of phytochemicals 
and their metabolites. In cases where phytochemicals are metabolised and conjugated 
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in the intestine and the liver, other organs could be exposed to metabolites of the 
original compound. These differences in tissue exposure to phytochemical metabolites 
could cause organ specific responses on a major signalling pathway as NF-κB.  
Knowledge of the tissue distribution of phytochemicals present in our extract is scarce, 
and data on phytochemical metabolomics is limited. However, a few studies have 
monitored radio-labelled phytochemicals after oral administration. A study on 
resveratrol distribution in mouse tissue revealed a preferential presence in the organs 
and biological liquids of absorption and elimination (stomach, liver, kidney, intestine, 
bile, urine) (71). Suganuma et al. (72) investigated the tissue distribution of 
epigallocatechingallate (EGCG) after oral administration in mice, and found EGCG or 
its derivatives in a wide range of organs; intestines, lung, liver, pancreas, skin, kidney, 
brain, uterus, ovary and testicles. Mullen et al. (73) investigated metabolisation and 
tissue distribution of [2-14C]quercetin-4’-glucoside, and found that the majority was 
rapidly conjugated in the intestines and incorporated into metabolites. There was 
limited absorption of quercetin into the blood stream and organs.  
The observed inhibition of NF-κB activity in specific organs indicates that bioactive 
compounds from the combination extract have been absorbed, and that these 
compounds or their metabolites modulate NF-κB signalling in the respective organs. 
Consistent with the observations done by Vitrac et al. (71), we found alterations in 
NF-κB signalling in organs of absorption and elimination; such as the intestines, liver 
and possibly also the kidneys. Ex vivo imaging reported a statistically significant 
inhibition of LPS-induced NF-κB activity in the intestines of the mice receiving 
combination extract. The LUC assay on tissue homogenates revealed statistically 
significant inhibition in the liver from the same treatment. High concentrations of 
phytochemicals in the intestines and liver are expected, as these organs are the main 
sites of phytochemical metabolism. Bioactive properties of phytochemicals in the 
digestive tract are supported by results from animal studies. Bobe et al. (74) found a 
reduction in tumour development after treatment with anthocyanins in a mural 
intestinal cancer model. Kim et al. (75) found that 3,3-Diindolylmethane (DIM),  
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an in vivo metabolite from cruciferous vegetables, significantly reduced inflammation 
and improved pathology from colitis, as well as reduced the number of tumours from 
colitis-associated colon cancer in mice. They also found that treatment with DIM 
reduced the NF-κB binding in the nuclei of colonic tissue cells, and further 
mechanistic in vitro experiments confirmed that DIM blocked IκB degradation and 
thereby nuclear translocation of NF-κB.  
The inhibition of NF-κB activity in the liver after treatment with the combination 
extracts is supported by other studies that have revealed liver specific effects of 
phytochemical-rich foods. Shimoda et al. (67) found that orally administered phenolics 
from walnut reduced carbon tetrachloride (CCl4)-induced liver injury in mice. They 
also found that activation of NF-κB is involved in the induction of liver damage in this 
model. Botsoglou et al. (76) investigated the effect of long term oregano feeding on 
the alleviation of CCL4-induced liver damage in rats, and found that oregano 
significantly reduced the circulating markers of liver damage post treatment. Sasaki et 
al. (77) found that both thyme and phenolic compounds from thyme (thymol and 
carvacrol) were able to induce production of cytoprotective phase I and II enzymes in 
the liver using a mouse model. Two coffee specific compounds, cafestol and kahweol, 
have shown anti-carcinogenic properties in a rodent model by modulating the activity 
of phase I and II enzymes (78).  
From the ex vivo imaging (Figure 5.6), all single extracts seem to cause a somewhat 
increased NF-κB activity in the liver, and for the thyme treatment, the LUC assay 
confirms this trend by showing a significant increase in NF-κB activity. The overall 
contribution of the liver to the NF-κB activity measured (as discussed previously) 
could explain some of the increased signal in vivo after treatment with walnut and 
possibly also clove, even though we did not find significant differences in the liver for 
these treatments. 
Interestingly, we observed effects also in the testicle and the epididymis. The 
combination extract inhibited NF-κB activation in both these organs, whereas the mice 
receiving thyme extract showed a significant increase in the NF-κB activity of the 
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epididymis. Clearly, the epididymis is sensitive to changes caused by phytochemicals.  
LPS injection induces ROS formation in cells (21;79), and DNA is susceptible to 
damage by ROS. The reproductive organs might be especially sensitive to changes in 
cellular ROS, as the testicle produces sperm (DNA is continually being replicated), 
and the epididymis matures the newly produced sperm.  
Treatment with the combination extract caused increase in NF-κB activity in the 
spleen. The clove extract caused a significant reduction of NF-κB activity in the spleen 
measured by ex vivo imaging; however, this was not supported by the LUC assay 
which is generally a more reproducible method for most tissues. Still, this adds to the 
observation that the combination extract seems to produce effects opposite of the 
single extracts.  
We found a significant increase in NF-κB activity at 6 hours in the walnut extract 
group measured by in vivo imaging. However, no organs showed a significant 
increased activity measured by ex vivo imaging or LUC assay. The overall increased 
NF-κB activity observed by in vivo imaging is probably caused by partial 
contributions of several organs emitting luminescence, though not showing 
statistically significant differences in our assays. 
A possible cross-talk between NF-κB and the cytoprotective proteins, which are 
induced by the transcription factor Nrf2, has been suggested (80;81).  
In vitro and in vivo experiments have revealed the dual ability of some phytochemicals 
(curcumin, resveratrol, EGCG, caffeic acid phenetyl ester (CAPE) and 
isothiocyanates, e.g. sulforaphane) and coffee to inhibit NF-κB activation and induce 
Nrf2 (5). Activation of the Keap1/Nrf2 pathway will result in transcriptional activation 
of several cytoprotective proteins involved both in the xenobiotic metabolisation and 
generation of endogenous antioxidants (3). If the combination extract activates 
cytoprotective gene transcription, the subsequent cellular stress by LPS is possibly 
lowered in the extract group, leading to an attenuated NF-κB activation. This 
observation fits the “hormesis theory”, i.e. phytochemicals can prepare the cells for 
stress by inducing the expression of cytoprotective proteins. According to the theory, 
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the molecular responses triggered by stress-inducing compounds do not only protect 
against the same compound, but also less specific stressors. Possibly, such responses 
can aid more general cellular stress conditions, such as oxidative, metabolic or thermal 
stress (32).  
6.2.3 Single extracts versus combination extract 
The effects observed in the combination extract experiment are difficult to interpret in 
context of the single extract experiments. As coffee extract alone proved to have an 
inhibitory effect on NF-κB in vivo (47), the coffee in the combination extract could 
possibly counteract or exceed the effect caused by the walnut or clove extract. The 
combination extract could also produce a very different response, due to interactions 
between the phytochemicals provided. Future analysis of the extracts’ bioactive 
compounds, and the distribution of phytochemicals and their metabolites in tissues, 
could provide new insight into these somewhat contradictory results.  
One important factor concerning the experiments with single plant extracts is the 
sample size. The combination extract experiment was repeated three times before the 
sample size was sufficient to yield statistically significant differences, due to rather 
large inter-individual variations. The results from single extract experiments need to be 
reproduced before conclusions about the effect on NF-κB activation can be drawn; 
however, for the combination extract, all the individual experiments in vivo were 
supporting results from in vitro.  
In vitro studies traditionally use cells from only one tissue. In live animals, the 
phytochemicals are absorbed, conjugated and distributed to tissues to various extents. 
Hence, the phytochemicals may influence several tissues, and in different ways. The 
fact that thyme, clove and walnut extracts produce different effects in vitro and in vivo, 
illustrates the complexity of the interplay between phytochemicals and physiological 
effects in a living organism. If the hormesis theory applies to our experiments, the 
doses we have used might have been too high, possibly causing an adverse effect 
instead of an inhibiting effect.  Examples of possibly adverse effects of phytochemical 
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supplements were seen in two studies on β-carotene and vitamin A, and β-carotene and 
vitamin E, respectively. These clinical trials were based on epidemiological studies 
indicating that dietary intake of carotenoids is linked to a reduced risk of developing 
chronic diseases. Supplementation of carotenoids in high doses, however, increased 
the prevalence of lung cancer and increased mortality from heart disease in smokers, 
and both trials were discontinued (82;83). This could suggest that positive health 
effects arise from normal dietary levels, whereas abnormally high amounts can have 
detrimental effects. Besides, even though a diet rich in β-carotene is protective against 
disease, β-carotene is not necessarily the protective agent. This might also be the case 
for other presumably bioactive dietary compounds. 
In nutritional science, this exemplifies the concern expressed by several scientists on 
the overwhelming promotion and use of antioxidant supplements. The antioxidant 
supplement industry might promote doses that exceed the normal, if not toxic 
threshold, potentially causing harm rather than protection. A substantial amount of 
evidence supports that a diet rich in plant foods protects against disease and prolong 
life expectancy. Exposure to small, continuous doses of phytochemicals provided by 
natural foods might be one part of the explanation for the observed protection.  
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7. Conclusion 
The object of this Master project was to follow up and continue previous work 
performed in the Rune Blomhoff research group on NF-κB modulating properties of 
phytochemical-rich plants. 
The treatment of transgenic reporter mice with combination extract showed an overall 
significant inhibition of LPS-induced NF-κB activity. Inhibition in the extract group at 
2 and 6 h were 40 % and 36 %, respectively. The AUC (0-6 h) was 35 % lower in the 
extract treatment group compared to the control group. The combination extract also 
had the ability to modulate NF-κB activation in an organ specific manner. Activation 
in intestines, liver, testicles and epididymis was significantly inhibited in the extract 
group, whereas the activity in the spleen was significantly increased. 
The in vivo treatments with single extracts (thyme, clove and walnut) revealed a higher 
NF-κB activity when the mice were treated with walnut extract, and possibly also with 
clove extract, than with LPS only. At 6 h, the NF-κB activation was 104 % higher in 
the walnut group compared to the control group, a statistically significant difference. 
We found organ specific NF-κB modulation also by single food extracts, particularly 
in the reproductive organs (testicle, epididymis) and in the spleen; however, the 
respective organs seem to respond in an opposite way after treatment with single 
extracts compared to the combination extract treatment.    
The observation that effects of phytochemical-rich plant extracts produce a different 
effect on NF-κB modulation in vivo than in vitro, illustrates the complexity of the 
interplay between phytochemicals and physiological effects in a living organism.  
As dietary plants contain an abundance of phytochemicals, a multitude of possible 
mechanisms of action could cause the effects observed.  
The results from this project have shown that dietary plants can influence NF-κB   
signalling. Further work should focus on revealing the bioactive substances in the 
extracts, and the mechanisms behind their NF-κB modulating properties. 
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1. Results from the combination extract experiment performed within this thesis. 
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Appendix 1: 
Results from the combination extract experiment performed within this thesis. 
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Effect of combination extract on LPS-induced NF-κB activity 
Transgenic NF-κB-luciferase reporter mice were given combination extract per os in a 
single dose 3 h prior to LPS injection (0h). NF-κB activation was measured by in vivo 
imaging at -3, 0, 2, 4, 6h, ex vivo imaging (at 6h) and LUC assay of individual organs. 
Sample size: n=4 control, n=4 extract. 
In vivo imaging 
Quantification of light emitted from whole mice revealed a trend towards inhibition of 
NF-κB activation in the mice receiving the combination extract compared to control 
mice. One representative mouse from each treatment is shown in figure 9.1A.  
At 2 hours after LPS injection, activation in the extract group was 37 % lower than in 
the control group (Figure 9.1B). At 6 h, it was 25 % lower. Total area under curve 
(AUC) (0-6 h) is 48.19 (95% CI: 18.11-78.27) for the extract group and 80.65 (95% 
CI: 33.80-127.48) for the control group (Figure 9.1C). This represents a 0.6 fold 
lower activation in the combination extract group compared to the control group. 
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Figure 9.1. Effect of combination extract in transgenic NF-κB reporter mice. In vivo imaging.  
Mice were given combination extract or control vehicle 3 h prior to LPS injection (0h). A) In vivo 
images of one representative mouse from each group. B) Mean ± SD fold change of luminescence 
(photons/second) from the whole mouse minus head and extremities. C) Box plot of area under curve 
(AUC) for control group and combination extract group.   
Ex vivo imaging 
Organ specific NF-κB activation can not be detected by in vivo imaging. To evaluate 
differences organs (brain, lung, heart, thymus, spleen, kidney, liver, intestines, skin, 
muscle, adipose tissue, testicle and epididymis) were excised and NF-κB activation 
was measured by ex vivo imaging.  
Ex vivo imaging after administration of the combination extract or vehicle control 
revealed that the combination extract was able to inhibit NF-κB activation in the 
epididymis (Figure 9.2B). The mean fold change is 0.62 ± 0.07. No other organs 
showed significant differences, although there seems to be a lower NF-κB activation 
in intestine and liver, and possibly an increased NF-κB activation in spleen, lung and 
skin. 
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Figure 9.2. Effect of combination extract in transgenic NF-κB reporter mice. Ex vivo imaging.  
LPS induced luciferase activity in organs after administration of combination extract or control 
vehicle. Organs were excised and imaged 6 h post LPS injection, luminescence was measured by 
imaging in an IVIS 100 imaging system, and quantified using the “Living Image software”. Gray scale 
images were used for reference of position. A: Representative organs from one control mouse (left) 
and one combination extract mouse (right). The orders of the organs are identical for both sets. B: 
Quantification of emitted light from organs. Bars represent mean fold change + SEM. * = p < 0.05 
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LUC assay 
NF-κB activity was measured in homogenates of organs (brain, lung, heart, thymus, 
spleen, kidney, liver, muscle, adipose tissue, testicle and epididymis). 
The NF-κB activity (Figure 9.3) decreased in testicle and epididymis in the 
combination extract group compared to the control group. The mean fold change was 
0.75±0.04, and 0.58±0.02, respectively. There might be a trend towards increased NF-
κB activity in the spleen.  
 
Figure 9.3. Effect of combination extract in transgenic NF-κB reporter mice. LUC assay.  
LPS induced luciferase activity in organs after administration of combination extract or control 
vehicle. Organs were excised 6 h post LPS injection, measured for luciferase activity and corrected for 
total protein content. Bars represent mean fold change + SEM. * = p < 0.05 
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Appendix 2:  
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Nuclear Factor kappa B in monocytes and in transgenic reporter mice.  
Unpublished work.  
 
 
Extract of oregano, coffee, thyme, clove and walnuts inhibits nuclear factor kappa B 
in monocytes and in transgenic reporter mice 
 
Ingvild Paur1, Trude R. Balstad1, Marit Kolberg1, Marit K. Pedersen1, Liv M. Austenaa2, David R. Jacobs Jr.1,3, 
and Rune Blomhoff1 
 
1 Department of Nutrition, Faculty of Medicine, University of Oslo, Norway. 2 The FIRC Institute of Molecular 
Oncology Foundation, European Institute of Oncology, Milan, Italy. 3 Division of Epidemiology and Community 
Health, School of Public Health, University of Minnesota, Minnesota, USA.  
 
 
Requests for reprints: Rune Blomhoff, Department of 
Nutrition, Faculty of Medicine, University of Oslo, 
P.O. Box 1046, 0316 Oslo, Norway, Fax: + 47 
22851396; E-mail: rune.blomhoff@medisin.uio.no. 
Running Title: Clove, oregano, thyme, walnuts and 
coffee inhibit NF-κB in vivo 
Keywords: NF-κB, diet, synergy, transgenic mice, in 
vivo imaging 
Financial support: This work was supported by grants 
from the Norwegian Cancer Society (IP, LMA and RB) 
and the Johan Throne Holst Foundation (RB and DRJ). 
Acknowledgements: The U937-κB cells were 
generously donated by Christian Drevon, Dept. of 
Nutrition, University of Oslo. We thank Hanne 
Reiersen, Lene Gilen and Kari Holte for technical 
assistance and Cgene for providing the IVIS100 
imaging system and the reporter mice. 
Conflicts of interest: RB has owner interests in Cgene 
AS which was established by Birkeland Innovation (the 
Technology transfer office at the University of Oslo) 
and holds the commercial rights to the transgenic NF-
κB-luciferase reporter mice. DRJ is an unpaid member 
of the Scientific Advisory Council of the California 
Walnut Commission. 
Abbreviations used: Nuclear Factor kappa B: NF-κB, 
Lipopolysaccaride: LPS, Inhibitor of NF-κB: IκB, IκB 
Kinase: IKK, Interleukin: IL, Tumor Necrosis Factor: 
TNF, Dimethylsulfoxide: DMSO, Ferric Reducing 
Ability of Plasma: FRAP, subcutaneously: s.c. 
 
Abstract  
The transcription factor nuclear factor kappa B (NF-
κB) is a promising target for chemoprevention. Several 
dietary plants are efficient inhibitors of NF-κB 
activation in vitro and could act synergistically on the 
NF-κB signaling pathway. In this study, we tested 
whether dietary plant extracts could inhibit NF-κB 
activation in a synergistic manner in vitro. Secondly, 
we investigated the potency of the same dietary plant 
extracts in inhibition of NF-κB activation in vivo. A 
combined extract of clove, oregano, thyme, walnuts 
and coffee synergistically inhibited lipopolysaccaride 
(LPS)-induced NF-κB activation in a monocytic cell 
line, as compared to the sum of effects from the single 
extracts. Transgenic NF-κB-luciferase reporter mice 
were administered a single dose of the combined 
extract, and subsequently challenged with LPS. NF-κB 
activation was monitored by in vivo imaging for 6h. 
Also, organ specific inhibition of NF-κB was 
investigated. Based on area under the curve, the extract 
decreased whole body LPS-induced NF-κB activity the 
first 6 hours by 35 % as compared to control mice. 
Organ specific NF-κB activation was inhibited in 
intestine and liver (to 53 % and 67 % of controls, 
respectively), and as well as in testis and epididymis (to 
66 % and 48 %, respectively) of the mice receiving the 
combination extract. This study shows that dietary 
plants may be potent modulators of the NF-κB 
signaling pathway both in vitro and in vivo, and thus 
support further investigation of consumption of these 
plant foods as part of a healthy diet or as a mode of 
chemoprevention. 
Introduction 
Recent studies have identified nuclear factor kappa B 
(NF-κB) as a direct link between inflammation and 
cancer (1-3) and thus renders this family of 
transcription factors as a key molecular target for both 
prevention and treatments of cancers. The NF-κB 
family of transcription factors are crucial mediators of 
cellular stress-, immune- and inflammatory responses 
(4). Although NF-κB is essential in normal physiology, 
several human disorders involve inappropriate 
regulation of NF-κB. Several chronic degenerative 
diseases (5-9) and various human cancers (10) have 
been associated with an aberrant up-regulation of NF-
κB activity. Both the NF-κB activation and cytokine 
profile of tumor-associated macrophages are closely 
linked to tumor growth (11;12).  
In vertebrates, the NF-κB family is comprised of five 
structurally related proteins (p65 (REL A), p50, p52, c-
REL, REL B) which form hetero- and homodimers. 
Normally the NF-κB dimers are sequestered in the 
cytoplasm by binding to inhibitory factors. Two 
pathways lead to delocalization of NF-κB dimers to the 
nucleus and consequent transcriptional regulation of 
target genes (13). The classical NF-κB signaling 
pathway is activated by pro-inflammatory stimuli, 
bacterial- or viral infection, and various forms of stress 
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such as UV-radiation and environmental toxins (14), 
and is essential for the innate immune system and anti-
apoptotic signaling. The alternative NF-κB pathway 
plays a critical role for both development and 
maintenance of the adaptive immune system, and is 
activated by members of the TNF family other than 
TNF-α (13). NF-κB target genes code for proteins 
which are central players in inflammation, activation of 
the immune system and anti-apoptotic signaling, which 
can be involved in both promotion and progression of 
cancers (15). With the central role of NF-κB activation 
in inflammation, cancer and anti-apoptosis, substances 
with the ability to inhibit NF-κB activation may be 
valuable in a generally healthy diet, in 
chemoprevention (16) and in combination with 
chemotherapy (17). 
Plants and plant-based diets contain thousands of 
phytochemicals (18) in addition to well known macro- 
and micronutrients. In epidemiological studies, diets 
rich in plant-based foods reduce the risk of several 
cancers (19), and several chronic diseases (20). Clinical 
trials with single compounds have, however, not been 
able to reproduce these risk reductions (19;21;22). For 
these reasons, it is likely that several of these 
compounds work in additive, synergistic or antagonistic 
fashions to create the observed health effects, and thus 
foods or combinations of foods may be better suited as 
the basic unit for research on these preventive effects 
(23). The preventive properties of such diets are likely 
to be complex combinations of numerous mechanisms. 
None the less, aberrant cellular signaling is a hallmark 
of carcinogenesis, and targeting crucial signaling 
pathways, such as the NF-κB pathway, yield valuable 
progress towards elucidation of the mechanisms 
underlying chemoprevention. We previously screened a 
wide range of dietary plants and phytochemicals for 
their effect on NF-κB activation and found clove, 
thyme, oregano, coffee and walnuts to be the most 
potent inhibitors (24). In this study, we demonstrate 
that an extract of these five dietary plants 
synergistically inhibit NF-κB activation in vitro, and 
can also inhibit NF-κB activation in vivo in transgenic 
mice. Interestingly, lowered NF-κB activation was 
detected in the liver and intestine, as well as in testis 
and epididymis of male mice, indicating organ specific 
effects of the dietary plants.  
 
Materials and Methods 
Cell culture  
U937-κB cells are previously described (25). Cells 
were cultured in RPMI-1640 medium with L-
gluthamine (2 mM), penicillin (50 U/ml), streptomycin 
(50 mg/ml), hygromycin (75 μg/ml), and 10% fetal 
bovine serum at 37ºC and 5 % CO2. During 
experiments, cells were seeded in medium with 2% 
fetal bovine serum. NF-κB activity was induced by 
lipopolysaccaride (LPS) (1 μg/ml). Cell viability was 
determined by trypan blue exclusion. A cut-off value of 
10 % non-viable cells was used.  
Dietary plant extract 
Coffee (Arabica, Medium roast), walnuts, oregano 
(dried), clove (dried), and thyme (dried) were 
purchased from a grocery store in Oslo, Norway. All 
samples were pulverized and 10g coffee, 10g walnuts 
plus 1g of each of oregano, thyme and clove were 
added equal volumes of water and methanol. The 
mixture was placed in an ultrasonic water bath for 30 
min at 0°C. The mixture was centrifuged at 3000 g for 
15 min, the liquid phase saved. Centrifugation was 
repeated to increase the yield of the liquid phase, 
thereafter the total liquid phase was concentrated under 
nitrogen gas to a viscid fluid. The concentrated extract 
was diluted to 5 ml in corn oil (extract used for mice) 
or a 50:50 mix of phosphate buffered saline 
(PBS):dimethylsulfoxide (DMSO) (v/v). The extract to 
be used for cell culture was thereafter sterile filtered 
and stored under argon gas in airtight tubes at -70°C. 
Transgenic mice 
The mice were housed in accordance with the 
guidelines of the Federation of European Laboratory 
Animal Science Associations (FELASA) and animal 
experiments were performed according to national 
guidelines for animal welfare. Transgenic mice with B6 
background carrying a transgene with three binding 
sites for NF-κB coupled to the luciferase gene have 
previously been described (25). A single dose of an 
extract corresponding to 60 mg each of thyme, oregano 
and clove, and 600 mg each of walnuts and coffee or 
vehicle control (corn oil), was administered by oral 
gavage to the mice (both groups: n = 16, 10 female and 
6 male, 11-24 weeks of age). No differences were 
found between the female and male mice, and thus the 
results from both sexes were pooled. LPS (2.5 mg/kg) 
in 100 μl PBS was injected subcutaneously (s.c.) on the 
back near the tail 3h after oral gavage. In vivo imaging 
was performed at the given time points. Directly 
following imaging at 6h, the mice were euthanized, ex 
vivo imaging of the intestine was performed, and all 
other organs were frozen in liquid nitrogen for further 
analysis. Luciferase activity in homogenates of organs 
was measured as previously described (25).  
Luciferase activity 
Luciferase activity was measured by use of an IVIS 100 
Imaging System (Xenogen Corp., USA). D-luciferin 
(0.2 mg/ml medium) was added to the cell culture 
medium, and cells were incubated at 37ºC for 4 min. 
Mice were anesthetized using 2.5 % isoflurane, and 
were shaved on the abdomen. D-luciferin (Biosynth 
AG, Switzerland) (160 mg/kg) in PBS was injected 
intraperitoneally, and mice were imaged 7 minutes after 
injection of D-luciferin. Cell culture plates or mice 
were placed in a light proof chamber, and the 
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luminescence emitted from the cells/mice was detected 
for 1 min. Ex vivo imaging of the intestine was 
performed 20 min after the injection of D-luciferin. The 
number of photons emitted was calculated by use of the 
Living Image Software (Xenogen Corp., USA). Gray 
scale images were used for reference of position. 
Statistical analysis for in vitro experiments 
The U937-κB cell cultures may vary in their NF-κB 
response to LPS depending on the passage of the cells. 
Therefore the control (no extract) response to LPS was 
idiosyncratic for each experiment, and the most stable 
set of experimental conditions is within a particular 
experiment. For these reasons, we set the control LPS 
level as 1, meaning 100% of NF-κB activity, and 
computed the responses to the LPS plus extract 
treatments as fold changes compared to controls.  
One-way ANOVA was used to examine effects of 
extracts, on NF-κB activity in U937-κB cells. 
Differences were identified using Dunnett’s 
comparisons. 
For the calculations of synergy, we used the natural 
logarithm of the NF-κB activity as the response metric, 
which takes a value of 0 for the control situation 
(response to LPS alone), a negative number for 
inhibition of the NF-κB activity to LPS plus extract, 
and a positive number for accentuation of the activity. 
We ran a linear regression model with dependent 
variable ln(NF-κB), with no intercept, that included as 
independent variables all 5 main effects of extracts, and 
a single term representing the combined extract. As the 
main test of synergy, we then estimated the contrast for 
the combined extract effect minus the sum of the 5 
corresponding main effects.  
Statistical analysis for in vivo experiments 
For in vivo experiments the area under the curve (AUC) 
of LPS-induced luciferase activity from 0 hours to 6 
hours, was calculated for each mouse. Student’s t-tests 
were performed to compare the data from AUC, at each 
time point, from ex vivo imaging, and from luciferase 
activity in tissue homogenates. Statistically significant 
difference was set to p<0.05 for all analysis. Results are 
presented as mean ± SEM, unless otherwise noted. 
 
 
Results 
Combined extract inhibits NF-κB activation in 
U937-κB cells 
An extract made from the combination of clove, 
oregano, thyme, walnuts and coffee inhibited LPS-
induced NF-κB activity in the U937-κB cells in a dose 
dependent manner (Fig. 1A). In the U937-κB cells, 
basal NF-κB activity was 0.05 ± 0.009 fold (5%) of 
LPS-induced NF-κB activity (Fig. 1A). The extract 
made from 0.3 mg/ml coffee- and walnut-, and 0.03 
mg/ml thyme-, oregano- and clove reduced LPS-
induced NF-κB activation to 0.74 ± 0.05 fold (p < 
0.001) of LPS-controls, while the extract made of 0.6 
mg/ml coffee and walnut, and 0.06 mg/ml thyme, 
oregano and clove further reduced luciferase activity to 
0.51 ± 0.04 fold (p < 0.001) of LPS-controls. Increasing 
the concentration to 1.5/0.15 mg/ml and 3/0.3 mg/ml 
(coffee and walnut/thyme, oregano, clove) almost 
completely blocked LPS-induced NF-κB activation to 
respectively 0.09 ± 0.02 fold and 0.08 ± 0.01 fold (p < 
0.001 for both) without cytotoxicity. 
Assessment of Synergy 
To test for synergy, we calculated the difference 
between the effects of the combined extract and the 
sum of effects for the 5 single ingredients tested 
separately. Effects of single ingredients are shown in 
Fig. 1B. When comparing equal concentrations of the 
ingredients (3 mg/ml each of coffee and walnut, and 0.3 
mg/ml each of thyme, oregano and clove), the 
combined extract inhibited NF-κB significantly more 
than the expected additive inhibitory effects from the 5 
ingredients tested separately (Table 1A) indicating 
synergistic effects by the combination extract. At 
combined extract concentration of 1.5 mg/ml each of 
coffee and walnut, and 0.15 mg/ml each of thyme, 
oregano and clove, the combined extract was still 
significantly more potent in inhibiting NF-κB 
activation as compared to the expected sum of 
inhibitions from the 5 ingredients at 3 mg/ml coffee and 
walnut, and 0.3 mg/ml thyme, oregano and clove 
(Table 1B). The combined extract concentration of 0.6 
mg/ml of coffee and walnut and 0.06 mg/ml of thyme, 
oregano and clove, was equally potent as the expected 
sum of the effects for 3 mg/ml of coffee and walnut, 
and 0.3 mg/ml of thyme, oregano and clove (Table 1C). 
A way of expressing the synergy is to note that 1/5th the 
total volume of food extract was needed to obtain equal 
NF-κB inhibition using the combined extract as was 
expected based on the separate effects of the individual 
food extracts. 
The combination extract inhibits NF-κB in 
transgenic mice 
Next, we investigated whether the combination extract 
could modulate LPS-induced NF-κB activity in vivo. 
An s.c. injection of LPS (160 mg/kg) increased NF-κB 
activity to a maximum of 15.7 ± 2.4 fold (n = 16) after 
4 hours as measured by whole body in vivo imaging of 
the luciferase activity. The extract or control vehicle 
(corn oil) was administered by oral gavage to mice 3 
hours (at time -3 h) prior to s.c. LPS-injection (at time 
0h). Whole body in vivo imaging was performed at 0, 2, 
4 and 6 hours (Fig 2A & B). At 2h (p = 0.043) and 6h 
(p = 0.041) after LPS-injection, the extract significantly 
inhibited the LPS-induced NF-κB activity, compared to 
mice treated with LPS only. Based on the AUC, the 
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extract decreased LPS-induced NF-κB activity the first 
6 hours by 35 % (p = 0.040) as compared to control 
mice (Fig. 2C).  
Following in vivo imaging at 6h, the mice were 
euthanized, and luminescence was measured in 
intestine by ex vivo imaging and in homogenates of 
other tissues. There was a significant reduction in NF-
κB activity to 0.53 fold (p = 0.028) of controls, in the 
intestine of mice receiving LPS plus the extract as 
compared to mice receiving LPS only, as measured by 
ex vivo imaging (Fig 3A). Representative intestines 
from the LPS-only and the LPS + extract treated mice 
are shown in Fig. 3B. Furthermore, comparing 
luciferase activity by luminometry of tissue 
homogenates of organs from mice receiving the extract 
to mice receiving LPS-only, revealed significantly 
decreased NF-κB activity in the liver (0.67 fold of 
control, p = 0.046), testis (0.66 fold of controls, p = 
0.007) and epididymis (0.48 fold of control, p =0.021) 
(Fig. 4C). In the spleen the NF-κB activity was further 
increased in the mice receiving the extract (1.57 fold of 
control, p = 0.047). Although there was a suggestive 
but not significant increase in heart NF-κB activity, no 
other differences in luciferase activity were found in 
brain, thymus, lung, kidney, fat, muscle, or uterus. 
 
Discussion 
Inhibitors of NF-κB carry great promise for both 
prevention and therapy in cancers and chronic 
inflammation. An extract made from coffee, walnut, 
thyme, oregano and clove inhibited NF-κB activation 
in U937-κB cells in a synergistic fashion as compared 
to the effects of the single extracts. Furthermore, by 
using non-invasive molecular imaging of transgenic 
NF-κB luciferase reporter mice we demonstrated that 
the same combined extract efficiently inhibit LPS-
induced NF-κB activation in vivo. 
As recently demonstrated NF-κB is a direct link 
between inflammation and cancer (1-3) and aberrant 
activation of NF-κB has been found in several types of 
human cancers (10). Inflammation coordinated through 
NF-κB activation will most often promote tumor 
growth (15), and inflammation-promoted tumor growth 
can be turned to tumor regression by inhibition of NF-
κB in cancerous cells (2). NF-κB is essential for 
survival and cytokine production of monocytes and 
macrophages (26), and further NF-κB activation in 
macrophages is associated with cancer development. 
The cytokine profiles of monocytes and macrophages 
are also closely linked to tumor growth (11;12). The 
observed decrease in LPS-induced NF-κB activation in 
the monocytic cell line as well as macrophage rich 
organs in vivo (i.e., liver and intestine) following 
administration of plant extracts suggest that such plant 
extracts may have chemopreventive effects. NF-κB 
inhibitors therefore have great potential both in cancer 
prevention and as parts of a chemotherapeutic regime 
(17). Also, to the extent that inflammation is an 
important factor in disease conditions other than 
cancer, the consumption of these foods should be 
regarded as part of a generally healthy diet. 
The inhibition of NF-κB activity in liver, testis and 
epididymis indicate that compounds from the extract 
have been absorbed and are bioactive after absorption. 
In the intestine, the extract may produce its effect both 
by acting in the intestinal lumen and after absorption 
into intestinal cells. Further work should be done to 
identify the bioactive compounds as well as the 
mechanisms of action, in all four organs. The intestine 
and liver are the main organs for metabolism of 
phytochemicals. There is limited knowledge on tissue 
distribution of phytochemicals present in our extract. 
however, quercetin, resveratrol and epigallocatechin 
gallate (EGCG) have, however, previously been 
detected in the intestine, liver, and testes of mice and 
rats (27-29). Consistent with these results, we would 
expect the highest concentrations of phytochemicals 
from our extract in these organs, and thus also a greater 
chance of detectible effects on a major signaling 
pathway such as NF-κB.  
Induction of another transcription factor; nuclear factor 
erythroid 2-related factor 2 (Nrf2), may affect the organ 
specificity of NF-κB responses as there are lines of 
evidence suggesting a cross-talk between the NF-κB 
and Nrf2 signaling pathways (30-32), and this cross-
talk is most likely to be evident in organs with the 
highest Nrf2-activity. A wide range of phytochemicals 
are known to activate Nrf2 leading to induced 
expression of phase 2 enzymes and endogenous 
antioxidants (collectively called cytoprotective proteins 
(33)), and many of these phytochemicals are also 
known to inhibit NF-κB (32). Like NF-κB, Nrf2 has 
been implicated in carcinogenesis and inflammation 
both in liver and the gastrointestinal tract (34-36), and 
an induction of cytoprotective proteins is an alternative 
approach to reducing the tissue damage caused by 
carcinogens or excessive inflammatory response. 
Phytochemicals are mainly metabolized in the intestine 
and liver. Thus, other organs will be exposed to 
metabolites or conjugates of the ingested compounds, 
possibly resulting in organ specific NF-κB responses. 
In the spleen and possibly in the heart, the LPS-induced 
NF-κB activation was further increased in the mice 
receiving extract. It should be noted, however, that the 
absolute NF-κB activity (adjusted for protein contents 
of the samples) in the liver is 8 fold and 4 fold higher 
than in spleen and heart respectively. In combination 
with the large size of the liver, this implies that the liver 
is contributing considerably more than any other organs 
to the overall NF-κB activity in the mice. We speculate 
that it would be an advantage to maintain a high NF-κB 
activity in the spleen during an infection to ensure the 
activity of adaptive immune responses, and that this 
activation of NF-κB might be through the alternative 
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NF-κB pathway which is important in both 
development and maintenance of the spleen (13).  
In the search for mechanisms behind the protective 
effects of plant-based diets, reductionistic approaches 
studying isolated compounds have dominated. Such an 
approach might fit well into pharmacological research, 
but in doing so, we might overlook additive, synergistic 
or antagonistic effects that arise from combinations of 
compounds found in plant foods and diets. Thus, we 
have chosen to make extracts of foods the focus of this 
study. In the present work, we found synergistic 
inhibitory effects on LPS-induced NF-κB activation 
with the combination of five dietary plant extracts, as 
compared to the sum of effects of the five individual 
extracts. Keeping the concentration for the single 
extracts constant, the inhibitory synergistic effect on 
NF-κB activation by the combined extract persisted 
even at half the concentration. At a level of 1/5th 
concentration the added concentration of extracted 
foods in the combined extract is comparable to each 
individual extract tested alone, meaning that the effect 
of the combined extract is not simply an effect of a 
higher dose of food. This underlines the potential of 
synergistic effects being created by a variety of foods. 
Such effects would not be detectable in a more 
reductionistic model. 
The most recent report from the World Cancer 
Research Fond/American Institute for Cancer Research 
(19) concludes that coffee is unlikely to have an effect 
on cancers of the pancreas or kidneys. At present there 
is limited evidence on effects of coffee intake on other 
cancers sites, however some epidemiological studies 
suggest preventive effects of coffee in the liver (37-39). 
In a large epidemiological study, we observed that 
intake of coffee was inversely associated with reduced 
death attributed to oxidative stress and inflammatory 
diseases (40). Oxidative stress and inflammation are 
both closely linked to NF-κB activation and are 
involved in cancer initiation and development (41;42). 
In this perspective, inhibition of NF-κB might 
contribute to the inverse relationship between coffee 
intake and disease, with the liver as a main target 
organ. 
Walnuts, clove, thyme and oregano are all rich in 
redox-active phytochemicals (43;44) however none of 
these dietary plants have been extensively studied with 
respect to chemopreventive properties. The observed 
NF-κB inhibition by our combination extract may, at 
least partly, be attributed to rosmarinic acid (45) found 
in thyme and oregano (46), or eugenol (47) found in 
clove (46), which are all identified as inhibitors of NF-
κB; however thymol, a major phytochemical in thyme, 
did not modulate NF-κB activity (24). Thyme- and 
oregano essential oils in combination decreased the 
levels of IL-1β and IL-6, as well as inflammation 
related tissue damage in a model of colitis (48), both of 
which may be a result of NF-κB inhibition in the colon. 
Also, thyme may induce the level of endogenous 
cytoprotective proteins in the liver (49). Walnuts are 
also a rich source of essential fatty acids with known 
anti-inflammatory properties (50). 
Approaches that focus on foods rather than single 
compounds should be valuable in future research to 
unravel the chemopreventive effects of foods. To our 
knowledge, this is the first report to indicate synergistic 
effects of foods on NF-κB activation, however more 
research is warranted to confirm and to expand the yet 
limited knowledge about these synergistic effects. Our 
experiments show that ordinary dietary plants may be 
potent modulators of the NF-κB signaling pathway 
both in vitro and in vivo, and thus support a role of 
chemoprevention through dietary means.  
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Tables 
 
Table 1  Assessment of synergy: difference in ln(NF-
κB) according to prediction from main effects of the 5 
ingredients in the combined extract compared to the 
effect of the combined extract 
 
* Concentrations: a/b mg/ml = a mg/ml of each of 
coffee and walnut and b mg/ml of each of clove, thyme 
and oregano 
 
Main effects     
Parameter Estimate SE t Value Pr > |t| 
     
A)     
Combined extract at 3/0.3 mg/ml* versus sum of 5 at 3/0.3 mg/ml     
Sum of 5 ingredients -0.42 0.21 -1.95 0.075 
Combined extract -2.14 0.23 -9.17 <.001 
Difference Combined extract versus Sum of 5 -1.72 0.44 -3.93 0.002 
     
B)     
Combined extract at 1.5/0.15 mg/ml* versus sum of 5 at 3/0.3 mg/ml     
Sum of 5 ingredients -0.42 0.24 -1.71 0.112 
Combined extract -1.99 0.27 -7.49 <.001 
Difference Combined extract versus Sum of 5 -1.57 0.50 -3.15 0.008 
     
C)     
Combined extract at 0.6/0.06 mg/ml* versus sum of 5 at 3/0.3 mg/ml     
Sum of 5 ingredients -0.42 0.20 -2.12 0.056 
Combined extract -0.26 0.21 -1.23 0.242 
Difference Combined extract versus Sum of 5 0.15 0.40 0.38 0.711 
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Figure Legends 
 
Figure 1 Dietary Plant Extracts inhibit NF-κB activation in vitro  
U937-κB cells were incubated with the indicated extract for 6.5h, and LPS was added for the last 6h. Luciferase 
activity was measured by imaging. Bars represent mean of 2 or 3 experiments each performed in triplicate ± SEM. * = 
p < 0.05. The image of one representative experiment is shown in the lower half of the figure. Luminescence was 
measured in photons/sec/cm2/steradian, and presented with the color bar. Gray scale images were used for reference of 
position. A) Bars indicate fold change in luminescence at the indicated dosage of the combined extract. B) Bars 
indicate fold change in luminescence at the indicated dosage of LPS or of LPS plus the single extract. 
 
Figure 2 Combination extract inhibits NF-κB in vivo  
Transgenic NF-κB-luciferase reporter mice were given a single dose of extract by oral gavage 3h prior to s.c. LPS 
injection (at 0h). A) The luciferase activity was measured by in vivo imaging at 0h, 2h, 4h and 6h (one representative 
mouse from each group is shown). B) The average fold change (± SEM) of emittance of photons/sec/cm2/steradian 
(normalized to 0h) at 0h, 2h, 4h and 6h from the whole mice minus the head, limbs and tail (LPS + extract = open 
squares, LPS only = closed circles) (n = 16). C) The AUC was calculated for each mouse and compared between the 
two treatment groups. The average photons emitted and AUC were compared using the Student’s t-test. * = p < 0.05. 
 
Figure 3 Combination extract inhibits NF-κB activation in intestine, liver, testis and epididymis  
Directly following imaging at 6h the mice were euthanized, and organs excised. A) Ex vivo imaging of the intestines 
was performed. The average fold change (± SEM) of luciferase activity from the intestines of LPS-only mice (grey 
bars) versus LPS + Extract mice (black bars) is shown. B) Image of one representative intestine of a mouse from each 
treatment group is shown. Luminescence was measured in photons/sec/cm2/steradian, and presented with the color bar. 
Gray scale images were used for reference of position. C) Luciferase activity was measured in tissue homogenates and 
normalized to the average of LPS-only mice. Mean ± SEM. WAT = White Adipose Tissue. Student’s t-tests were used 
to compare the two treatments. n = 16 for all organs except uterus n = 10, testis & epididymis n = 6. * = p < 0.05 
 
 



